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Identification of signalling pathways regulating TBX2 gene expression and its target genes  
 
Huajian Teng 
Division of Medical Biochemistry, Faculty of Health Sciences, University of Cape Town, 
Observatory, 7925, Cape Town, South Africa 
February, 2008 
 
Members of the T-box family of transcription factors provide an important link between 
development and cancer. T-box factors play critical roles in embryonic development and results 
from recent studies suggest that they function in controlling cell cycle progression and also in the 
genesis of cancer. Importantly, the T-box factors Tbx2 and Tbx3 are overexpressed in several 
cancers including melanoma, small cell lung carcinoma, breast, pancreatic, liver and bladder 
cancers and can suppress senescence, a cellular process which serves as a barrier to cancer 
development. However, the precise role of most T-box factors is poorly defined, in part, because 
their target genes are still poorly characterised and very little is known of the signalling pathways 
that regulate their expression and activity.  
 
The broad aim of this study was therefore to contribute towards the identification of Tbx2 target 
genes as well as to identify signalling pathways that regulate TBX2 expression. The specific aims 
were thus to (1) investigate the regulation of type1 collagen gene expression by Tbx2; (2) clone 
the human TBX2 regulatory region and to identify cis-acting elements involved in the basal 
transcription of the TBX2 gene and (3) investigate the regulation of TBX2 gene expression by 
signalling pathways. 
 
Microarray analysis have previously implicated the collagen I genes as potential Tbx2 targets. To 
further investigate this possibility, this study firstly examined the expression of TBX2 in several 
human fibroblast cell lines and show that it while it is expressed in normal fibroblasts, it drastically 
reduced in its transformed counterparts. This pattern of TBX2 expression correlated with that 
observed for the human α2(1) collagen gene (COL1A2). Interestingly, stable expression of 
transfected TBX2 in transformed fibroblast cell lines further reduced expression of the human 
endogenous COL1A2 gene. This ability of Tbx2 to repress the human COL1A2 gene was 













To better understand the molecular mechanisms regulating TBX2 gene expression, the 5’-
flanking region of the human TBX2 gene was isolated and characterized. The proximal promoter 
(-216/+32) was shown to mediate most of the basal activity and a proximal Sp1 site juxtaposed to 
an inverted CCAAT box element were both shown to be essential for basal promoter activity. 
While a physical and functional interaction between Sp1 and NF-Y was not essential for optimal 
basal promoter activity, a dynamic balance in their levels appears to be important. Furthermore, 
the data reveal a potential downstream promoter element in the TBX2 promoter which 
significantly influences basal activity.  
 
Finally, this study explored the regulation of TBX2 expression by signalling pathways and 
demonstrated that 12-O-tetradecanoylphorbol-13-acetate (TPA) induces TBX2 expression in 
normal human fibroblasts in a Protein Kinase C (PKC)-dependent and Mitogen Activated Protein 
Kinase (MAPK) independent manner. However, the MAPK signalling pathways were implicated in 
regulating TBX2 gene expression in transformed human fibroblasts. The data further revealed 
that TPA activates transcription of TBX2 through histone H3 phosphorylation, and thereby 
recruiting Sp1 to the TBX2 gene. In addition, TPA activated mitogen- and stress-activated protein 
kinase 1 (MSK1) which correlated with phosphorylation of histone H3 in a PKC-dependent and 
MAPK-independent manner. This study is the first to provide evidence that phosphorylation of 
histone H3 leads to the transcriptional activation of the TBX2 gene and to link MSK1 to the PKC 





























1.1. T-box gene family 
 
The T-box family of transcription factors plays a central role in embryonic development 
and is an important aspect of developmental biology. T-box genes encode a family of 
transcription factors that are characterized by a conserved DNA binding domain called 
the T-box. Members of the T-box gene family have been identified in a wide variety of 
animal species ranging from Hydra to humans and play remarkably important roles in 
embryonic development such as the specification of primary germ layers and cell fates 
during organogenesis (Papaioannou, 2001; Showell et al, 2004; Naiche et al, 2005). 
Their important regulatory roles in development have been dem nstrated by mutational 
studies where mutant alleles, including heterozygotes, commonly give a phenotype. For 
example, the prototype of the family, the T-gene (Herrmann et al., 1990) encodes the 
Brachyury transcription factor (Kispert et al., 1995), and mutations within this gene affect 
mesoderm induction, while mutations in the human Tbx3 and Tbx5 genes result in the 
autosomal dominant Ulnar-Mammary (Bamshad et al., 1997) and Holt-Oram (Li et al., 
1997) syndromes respectively. Both syndromes are characterized by developmental 
defects; in Ulnar-Mammary syndrome the limb and apocrine glands are affected, while 
Holt-Oram syndrome is characterized by abnormalities in the cardiac septum and 
forelimbs. Dosage sensitivity or haploinsufficiency is postulated to be the mechanism by 
which mutations in T-box genes are responsible for these developmental defects. In 
addition to naturally occurring mutations, targeted disruption of the mouse Tbx6 gene 
results in an embryo in which the somites are transformed into neural tubes (Chapman 
and Papaioannou, 1998) while disruption of the Tbx4 and Tbx5 genes affect limb identity 
(Rodrigues-Estaban et al., 1999; Takeuchi et al., 1999).  
 
The prototype T-box family member, Brachyury (or T for Tail) has long been known to 
play an important role in mouse development, and was cloned from mouse by Herrmann 
et al. in 1990. Brachyury was first identified to be a member of a protein family when a 
study in Drosophila melanogaster showed that the DNA binding sequence of the omb 
gene is highly homologous with that of Brachyury (Pflugfelder et al., 1992). In 1994, work 











number of T-box members have been identified that share the conserved DNA binding 
domain. To date, 19 T-box members have been characterized in vertebrates and, based 
on phylogenetic analysis, the T-box gene family was shown to fall into several 
subfamilies (Fig. 1.1.) (Naiche et al., 2005). 
 
T-box proteins are DNA-binding transcription factors because they recognize and bind 
specific DNA sequences to regulate their target gene expression. Sequence 
characterization to identify a Brachyury binding motif revealed a palindromic sequence 
(TTT(G/C)ACACCTAGGTGTGAAA) to which Brachyury binds as a monomer or dimer 
(Kispert et al., 1993). To date, all members characterised have been shown to bind the 
core sequence GGTGTGA, referred to as the T-element, as monomers (Wilsion and 
Conlon, 2002). Some members have, however, been shown to recognize several non-
canonical sequences (Ghosh et al., 2001; Carreira et al., 1998; Lingbeek et al., 2002). 
Although all T-box proteins recognize similar DNA sequences, several lines of evidence 
indicate that they regulate different target genes which may depend on the promoter 
context and cofactors (Conlon et al., 2001; Muller et al., 1997; Coll et al., 2002). 
As transcription factors, T-box proteins have been shown to either activate or repress 
gene expression and transcriptional regulatory domains have been mapped in several T-
box proteins (Kispert et al., 1995; Stennard et al., 2003; Zaragoza et al., 2004). Recent 
studies have shed light on some of the mechanisms by which T-box factors regulate 
their target genes. For example, Tbx19 was shown to activate transcription by recruiting 
SRC/p160 coactivators to its cognate DNA target in the pituitary pro-opiomelanocortin 
gene promoter (Maira et al., 2003). Tbr1 on the other hand forms a complex with the 
nucleosome assembly proteins CASK and CINAP to regulate expression of genes such 
as NR2b and reelin (Wang et al., 2004). Interestingly, a recent study revealed that 
interaction of the Xenopus T-domain protein Xbra with Smad1, an effector of BMP 
signalling, prevents it from inducing expression of goosecoid (Messenger et al., 2005). 
Despite these contributions, there is still a paucity of information regarding the molecular 





























Figure 1.1. Schematic phylogenetic tree of the T-box gene family of vertebrates, 
showing the relationship of genes in the five subfamilies indicated by brackets on the 
right. All of these genes are present in mammals with the exception of the zebrafish 












This review will provide a general overview of the current literature available on the 
regulation of Tbx2 gene expression and its target genes, and will introduce key areas of 
research pertaining to this thesis. 
 
1.2. Tbx2 
In mice, Tbx2 is expressed in adult heart, lung, kidney, ovary and in cells of the 
melanocyte lineage (Bollag et al., 1994; Carreira et al., 1998) and in humans it is 
expressed in a wide variety of tissues including fetal kidney and lung as well as in a 
number of adult tissues such as kidney, lung, placenta, ovary, prostate, spleen, testis, 
breast, heart, thymus, intestine and polymorphonucleocytes (Law et al., 1995; Campbell 
et al., 1995). Human Tbx2 has not yet been linked to any known genetic syndrome but 
has been implicated in limb, heart and mammary gland development (King et al., 2006; 
Plageman and Yutzey, 2005; Rowley et al., 2004). Targeted mutagenesis to investigate 
Tbx2 function in mice have shown that heterozygous mutants appear normal while 
homozygous mutants die between 10.5 and 14.5 days post coitum of cardiac 
insufficiency (Plageman and Yutzey, 2005). This result suggests a crucial role for Tbx2 
during cardiac development. 
In addition to its key function in development, evidence is accumulating to suggest a role 
for Tbx2 in cancer. For example, Tbx2 and the very closely related factor Tbx3, have 
been implicated in cell cycle regulation and their expression is upregulated in a number 
of cancers, including breast (Sinclair et al., 2002; Fan et al., 2004), pancreatic 
(Mahlamäki et al., 2002; Hansel et al., 2004), melanoma (Vance et al., 2005; Hoek et al., 
2004), liver (Renard et al., 2007) and bladder (Ito et al., 2005). Both Tbx2 and Tbx3 
function as transcriptional repressors (Carreira et al., 1998; Carlson et al., 2001; He et 
al., 1999; Sinha et al., 2000), and have been shown to prevent senescence through a 
mechanism involving their ability to repress the cyclin dependent kinase inhibitors (Cdkis) 
p19ARF (Jacobs et al., 2000; Brummelkamp et al., 2002; Lingbeek et al., 2002) and 
p21WAF1/CIP1/SDII (referred to as p21) (Prince et al., 2004; Vance et al., 2005). 
Tbx2 encodes a transcriptional repressor and belongs to the Tbx2 subfamily which also 
includes Tbx3, Tbx4 and Tbx5. In mouse, Tbx2 is located within chromosome 11 (Bollag 
et al., 1994) and in humans, TBX2 has been mapped to chromosome 17q23 (Campbell 
et al., 1995). The T-box region of the human TBX2 transcription factor shares 90% DNA 











(Law et al., 1995). Both human and mouse Tbx2, which span 3.378 kb and 2.281 kb 
respectively, possess 7 exons 
 
The human Tbx2 protein consists of 702 amino acids with the T-box DNA-binding 
domain located at amino acids 104-285, whereas in mouse the T-box is located at amino 
acids 114-295 within the 711 amino acid protein. Due to the high degree of homology 
between the DNA-binding domain of Brachyury and Tbx2, investigators have utilised 
Brachyury as a model to gain insight into the DNA-binding specificity of Tbx2. These 
studies show that Tbx2 binds as a monomer to the Brachyury single half-sites (Carreira 
et al., 1998) and that it binds both the Brachyury palindromic and half sites equally well 
(Sinha et al., 2000). Mutating an arginine at position 122, which is conserved in all T-box 
factors, abolished the DNA-binding activity of Tbx2 in vitro without affecting its stability 
and nuclear localisation (Sinha et al., 2000). 
Despite the potentially important role that Tbx2 plays in development and carcinogenesis 
as desribed above, the precise molecular function of Tbx2 is still relatively poorly 
understood. An improved understanding of this role of Tbx2 would require the 
elucidation of how Tbx2 gene expression is regulated, as well as the identification of 
potential Tbx2 target genes. The next section provides an overview of the, limited, 
studies carried out to date in this regard. 
 
1.2.1. Tbx2 and its target genes  
 
Tbx2 functions to control cell differentiation, proliferation and fate through 
transcriptionally repressing its target genes. Tbx2 expression has been observed in 
several melanocyte and melanoma cell lines but not in pre-melanoblast cells (Carreira et 
al., 1998). Melanoblasts are neural crest derived cells which migrate to the hair follicles 
and epidermis where they differentiate into mature melanocytes capable of producing 
pigment (Silvers, 1979). While Tbx2 was first identified to repress the promoter of the 
melanocyte-specific tyrosinase-related protein 1 by binding the consensus T-box motif 
GTGTGA, it was also shown to bind the non-canonical GTGTTA and GGGTGA 
sequences in vitro (Carreira et al., 1998).  
 
Recent studies have identified several Tbx2 target genes that play a role during early 











requires a distinct set of genes, and a number of chamber and non-chamber specific 
genes have been characterised. For example, expression of natriuretic precursor 
peptide type A (Nppa), connexin (Cx) 40, and Cx43 are important for the differentiation 
and formation of the chamber myocardium (Christoffels et al., 2000; Christoffels et al., 
2004). Formation of the non-chamber myocardium on the other hand requires the 
expression of a different set of genes which involves Tbx2 (Christoffels et al., 2004; 
Habets et al., 2002). Tbx2 normally inhibits cell proliferation and chamber differentiation 
in non-chamber myocardium, and it is thought that chamber differentiation requires 
repression of Tbx2 by Tbx20 (Cai et al., 2005). Tbx20, a positive regulator of chamber 
formation, binds and transcriptionally represses Tbx2 via a T-element (Cai et al., 2005). 
Given the ability of Tbx2 to repress Nmyc1, which is required for the normal proliferation 
of the heart (Davis and Bradley, 1993), it is proposed that in chamber myocardium 
Tbx20 represses Tbx2 thus preventing its repression of Nmyc1 (Cai et al., 2005). 
However, in non-chamber myocardium repression of Tbx2 by Tbx20 is abolished, 
allowing Tbx2 to repress Nmyc1 and the early cardiac genes, resulting in decreased 
proliferation within this region (Cai et al., 2005; Stennard et al., 2005). In vitro reporter 
assays and transgenic mice studies have shown that during non-chamber myocardium 
formation, Tbx2 represses the transcription of Nppa, Cx40, and Cx43 and thus plays a 
role in regulating the formation of the multi-chambered heart (Christoffels et al., 2004; 
Habets et al., 2002). 
 
During heart development the non-chamber myocardium retains the embryonic 
myocardial phenotype of the tubular heart longer than the chamber myocardium. The 
Nppa gene is specifically expressed in the developing chamber myocardium and is one 
of the first hallmarks of chamber formation (Christoffels et al., 2000), which raises the 
question of how this gene is repressed in the non-chamber myocardium. This was 
addressed by studies which found that mutating two adjacent binding sites for T-box 
factors and Nkx2.5, respectively, abrogated repression of Nppa in regions of the non-
chamber myocardium (Habets et al., 2002). Furthermore, Tbx2 was shown to co-operate 
with Nkx2.5 to suppress Nppa promoter activity in embryonic myocardium (Habets et al., 
2002). Interestingly, the physical and functional interaction between Nkx2.5 and Tbx5 
were shown to be involved in synergistically activating an Nppa-reporter gene (Bruneau 
et al., 2001; Hiroi et al., 2001). Moreover, Tbx2 was shown to decrease Nkx2.5-Tbx5-











researchers believe that Nppa expression is regulated by the competition between Tbx2 
and Tbx5 to bind and cooperate with Nkx2.5.  
 
Tbx2 has been shown to regulate expression of the genes encoding connexin (Cx) 43 
and collagen, which are factors involved in bone formation. Gap junctions, composed of 
connexin protein subunits, function to connect the cytoplasm of adjacent bone 
(osteocytes) cells and are therefore important in cell-cell communication. Cx43 is the 
predominant gap junction protein in bone and its regulated temporal pattern of 
expression has been shown to play a critical role in normal ossification and osteoblast 
function (Lecanda et al., 2000). Tbx2 and Cx43 are co-expressed in osteogenic 
progenitors and osteoblasts, which suggested that Cx43 may be a potential Tbx2 target 
gene. This was tested in a study in which a rat osteosarcoma cell line was transfected 
with either sense or anti-sense Tbx2 and the results showed that inhibition of Tbx2 
resulted in a marked increase in Cx43 expression (Borke et al., 2003; Chen et al., 2004). 
The Cx43 promoter has several T-element half sites and Tbx2 was shown to directly 
bind and repress the Cx43 promoter at two of these sites (Chen et al., 2004). 
Interestingly, in the same study transgenic mice injected with the LacZ reporter cloned 
downstream of either the wild-type (WT) or mutant Cx43 promoter in which the two T-
elements were mutated exhibited the same expression pattern of LacZ (Chen et al., 
2004). These results suggest that in vivo, Tbx2 may require other factors to regulate 
Cx43 expression. It is also important to note that these studies were done in mouse and 
rat, suggesting that the role of Tbx2 during bone development may vary between 
species.  
 
Type 1 collagen synthesis is crucial for normal embryonic development and in 
maintaining tissue integrity, and its aberrant expression has deleterious effects on 
several biological processes including bone development (Bornstein and Sage, 1989). In 
an attempt to identify genes that may be regulated by Tbx2, cDNA microarray analysis 
was performed on mouse NIH 3T3 fibroblasts overexpressing Tbx2 and results revealed 
that the type 1 collagen gene was upregulated (Chen et al., 2001). Interestingly, a 
parallel investigation in which Tbx2 was overexpressed in the rat ROS17/2.8 
osteoblastic cell line showed downregulation of type 1 collagen (Chen et al., 2001). 











collagen genes by functioning as either a co-activator or a co-repressor depending on 
the cell context and/or the species. 
 
A possible mechanism for how Tbx2 may contribute towards the oncogenic process is 
suggested by studies which have shown that it is able to function as an immortalizing 
gene that enables cells to bypass senescence (Jacobs et al., 2000;). The main 
mediators of senescence are the Cdkis, p21 and p16INK4a, with p21 thought to be 
necessary for initiating the senescence-like growth arrest and p16INK4a required for 
maintenance of the state (Stein et al., 1999). In an attempt to investigate the potential 
mechanism by which Tbx2 causes mouse embryo fibroblasts to bypass senescence, 
p19ARF was revealed as a candidate target gene of Tbx2 (Jacobs et al., 2000). 
Subsequent work showed that the p14ARF (human homolog of p19ARF) promoter contains 
a functional Tbx2 binding motif (Lingbeek et al., 2002). Tbx2 was also shown to directly 
repress p21WAF through binding a putative T-element in its promoter (Prince et al., 2004). 
Interestingly, loss of Tbx2 function in mouse embryos has no effect on the expression of 
p21WAF and p19ARF (Harrelson et al., 2004) which suggests that another factor, such as a 
closely related T-box member, may substitute for Tbx2 in the cell cycle. The possibility 
that Tbx2 may contribute to the oncogenic process by inhibiting senescence is 
supported by a study that showed that expressing a dominant-negative Tbx2 in B16 
mouse melanoma cells led to increased levels of p21 and induction of senescence 
(Vance et al., 2005). 
 
1.2.2. Regulation of Tbx2 gene expression 
 
Given the critical role that Tbx2 plays in embryonic development and its implication in 
carcinogenesis it is important to understand the signalling pathways which regulate its 
gene expression. The role of Tbx2 seems to be tightly linked to the activity of the Bone 
morphogenic proteins (BMPs), Sonic hedgehog (Shh), and Wnt signalling pathways and 
a few examples supporting this are discussed below. 
 
 BMPs belong to the TGF-β family of signalling transducers and are important in the 
development of the non-chamber myocardium (Délot, 2003). There is accumulating 
evidence that both Tbx2 and Tbx3 may be downstream Bmp2 targets during heart 
development. Firstly, the expression patterns of Tbx2 and Tbx3 overlap significantly with 











expression of Bmp2 was shown to induce Tbx2 and, to a lesser extent, Tbx3 expression 
in non-cardiogenic tissue that is competent to form cardiac tissue. Moreover, in the same 
study when chick cardiac tissue explants were incubated with Noggin, a panantagonist 
of BMP signalling, Tbx2 was downregulated with only very little effect on Tbx3. 
Furthermore, mouse bmp2-//- embryos show marked morphological abnormalities in 
cardiac development (Zhang and Bradley, 1996) and Tbx2 gene activity is substantially 
reduced in the cardiac region of these embryos (Yamada et al., 2000).  
 
The hypothalamus is situated in the area of the brain just below the thalamus and is 
important in regulating body temperature, blood pressure, weight regulation, and many 
other autonomic-nervous system activities such as fear, rage and sexual behaviors (van 
de Graaff, 2002). Both in vitro and in vivo studies have implicated Tbx2 in the patterning 
and development of the hypothalamus. Much of the evidence for this results from work 
done in chick on a subset of hypothalamic cells, termed the ventral tubero-mamillary (vt-
m) cells which arise from a set of floor plate-like precursors (Manning et al., 2006). The 
floor plate-like precursors initially express Shh but require its downregulation in order to 
progress to vt-m cells. BMPs have previously been shown to downregulate Shh in a 
wide variety of tissues and Manning et al. (2006) show that downregulation of Shh in the 
vt-m cells occurs by a BMP-Tbx2 signalling pathway. Both overexpression and knock-
down experiments showed that Tbx2 downregulates Shh in the vt-m hypothalamus. 
Furthermore, Jeong and Epstein (2003) identified a T-element in the mouse Shh 
promoter and they show that mutating this T-element results in aberrant expression of 
Shh within the hypothalamus. In Manning et al. (2006), BMPs were shown to upregulate 
Tbx2, which may involve the ability of BMPs to antagonise Wnt. In the presence of the 
BMP inhibitor, chordin, expression of Tbx2 was downregulated in the vt-m hypothalamus. 
In contrast, blocking BMP and Wnt signalling was shown to rescue the expression of 
Tbx2 in the vt-m cells. The results by Manning et al. (2006) raise the possibility that the 
T-element in Shh is regulated by Tbx2 in the hypothalamus. 
 
While several signalling pathways, including those mentioned above, have been 
associated with the regulation of Tbx2 expression, the details of this regulation remain 
largely unknown. Furthermore, key cis-acting elements responsible for Tbx2 gene 
expression have not yet been identified, and relatively few studies have reported on the 











mouse Tbx2 gene has been cloned and the transcription factor Mitf was shown to 
activate Tbx2 gene expression by recognizing an E-box element in melanocytes 
(Carreira et al., 2000). A putative retinoic acid response element was also identified in 
this promoter and it was shown to be responsible for retinoic acid stimulated Tbx2 gene 
expression (Boskovic and Niles, 2004). Both Tbx2 and Tbx20 play a role in heart 
development and a recent study showed that Tbx20 was able to bind in vivo to a 5’-
regulatory region of the mouse Tbx2 gene, which contains a putative T-element. This 
finding suggested that Tbx2 is a direct target for repression by Tbx20 in the developing 
heart (Cai et al., 2005).  
 
A major aspect of the current thesis was to clone the 5’- regulatory region of the human 
Tbx2 and to identify cis-acting elements involved in its expression and hence the next 
section will provide an overview of the areas relevant to this study. 
 
1.3. Cis-acting elements in the proximal promoters of eukaryotic genes 
 
Transcriptional control is the key means of regulating gene expression. In eukaryotes, 
transcription of protein-coding genes is carried out by RNA polymerase II, a multisubunit 
complex. RNA polymerase II requires a number of general transcription factors to 
recognize the transcription start site and forms a stable transcription-initiation complex 
with these factors. The core promo er is identified as a DNA sequence to which RNA 
polymerase II binds directly and which determines the site of transcription initiation. 
Typically, the core promoter comprises DNA sequences within -40 to +40 nucleotides 
relative to the transcriptional start site. In addition to the core promoter, the proximal 
promoter (approximately 200 bp) generally contains multiple recognition sites for 
sequence specific-binding transcription factors (Blackwood and Kadonaga, 1998; Butler 
and Kadonaga, 2002). A schematic diagram of cis-acting elements typically found in a 
proximal promoter is depicted in Fig 1.2. 
 
1.3.1. Core promoter elements 
 
Several types of core promoter elements have been well characterized, including the 
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Figure 1.2. Structure of the proximal promoter of a typical eukaryotic protein-coding 
gene. Some potential regulatory elements are depicted. The core promoter includes the 
TATA box, Initiator (Inr) and downstream promoter element (DPE). Usually, only one or 
two of these core promoter elements are found in a specific gene. Some genes contain 
none of these elements. Immediately upstream of the core promoter (from -50 to 
approximately -200 relative to start site), there are typically multiple elements for 
sequence-specific DNA-binding transcription factors. Sp1 and CCAAT box elements are 
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1.3.1.1. The TATA box 
 
The TATA box was the first eukaryotic core promoter element to be identified 
(Breathnach and Chambon, 1981). The TATA box is an A/T-rich sequence, typically 
located from -25 to -30 bp relative to the transcription start site. The consensus 
sequence for the TATA box is TATAAA. Various non-canonical sequences have, 
however, also been reported that can function as a TATA box (Singer et al., 1990). A 
statistical analysis of 1031 human core promoters indicated that approximately 32% 
have a potential TATA-box motif (Suzuki et al., 2001). The TATA-box is bound by the 
TATA box-protein (TBP), which is a key component of transcription factor IID (TFIID) 
which is a general transcription factor.  
 
1.3.1.2. The Inr element 
 
The Inr element was defined as a core promoter el ment of discrete function. It 
encompasses the transcription start site, and its consensus sequence in mammals is Py-
Py A (+1) N T/A Py Py (Bucher, 1990; Corden et al., 1980). Although the Inr can function 
independently, it was often found to cooperate with other core promoter elements and 
has been shown to be recognized by TFIID (Burke and Kadonaga, 2006).  
 
1.3.1.3. The DPE 
  
The DPE is most commonly found in TATA-less promoters and it seems likely that it is a 
compensatory eleme t for the TATA box. The DPE is generally found at a downstream 
position (+28 to+34) and its consensus sequence is A/G-G-A/T-C/T-G/A/C. A functional 
Inr element is often found in the DPE-dependent promoters. Although the DPE has been 
shown to be present in human genes, most work reporting on its involvement in 
transcriptional regulation has focused on Drosophila genes (Smale and Kadonaga, 2005; 

















1.3.2. Promoter-proximal elements 
 
In addition to the elements found in the core promoter, DNA motifs for sequence-
specific DNA binding transcription factors are also needed for efficient transcription of a 
specific gene. These elements reside in the proximal promoter and are typically located 
-40 to -200 bp from the transcription start site. The Sp1 and CCAAT box motifs will be 
discussed in more detail in this review because they are the most common promoter-
proximal elements and are of particular importance to this study. 
 
1.3.2.1. The CCAAT box  
The CCAAT box is one of the most common cis-acting elements present in the promoter 
of eukaryotic genes. A statistical analysis of eukaryotic genes revealed that the CCAAT 
box element is present in 30% of the 502 promoters analysed (Bucher et al., 1990). 
Typically, the CCAAT box is found as a single copy element in either the forward or 
reverse orientation from -60 to -100 bp relative to the transcriptional start site. As a 
critical cis-acting element, the CCAAT box motif has been shown to be essential for 
basal transcription of many genes. The extent of dependence on the CCAAT box motif is 
variable and depends on the context of promoters. In relatively simple TATA box-less 
promoters containing only one or two elements, the CCAAT box is absolutely necessary 
for gene transcriptional activation. In contrast, the CCAAT box motif is somewhat less 
important for some TATA box-containing promoters. Although several nuclear factors 
have been described to bind the CCAAT box motif, it is now well-documented that NF-Y 
is the major binding factor.  
NF-Y is a transcription factor complex that consists of three subunits, NF-YA, NF-YB and 
NF-YC, all of which are required for CCAAT box binding. NF-Y is highly conserved 
among species, and is ubiquitiously expressed. The consensus sequence for NF-Y is C 
G/A G/A CCAAT C/G A/G C A/C (Mantovani, 1998; Mantovani, 1999; Maity et al., 1998). 
A tight association between NF-YB and NF-YC is required for NF-YA binding and further 
binding of the three subunits to the CCAAT box. NF-Y has also been shown to associate 
with TATA box binding protein (TBP) (Bellorini et al., 1997) and several TBP-associated 
factors (TAFs) (Frontini et al., 2002). In a recent study, Kabe et al. (2005) have shown 











containing genes. These findings are consistent with the important role of the CCAAT 
box element in gene transcription.  
 
1.3.2.2. The Sp1 element 
 
The Sp1 element is a G/C-rich motif and was initially identified as the specific binding 
element for the transcription factor Sp1. Sp1 sites are functional in both forward and 
reverse orientation with the consensus sequence being G(T)GGGCGG(G/A) (G/A)(C/T) 
(Kadonaga et al., 1986).  A large number of genes have been shown to contain one or 
more Sp1 sites and they play a particularly critical role in maintaining gene expression in 
genes that lack a TATA-box. As is the case for NF-Y, Sp1 was also shown to associate 
with TBP and several TAFs (Emili et al., 1994; Chiang et al., 1995; Tanese et al., 1996). 
Although a single Sp1 site has been shown to be sufficient for Sp1 transcriptional 
activation, multiple Sp1 sites or additional cis-acting elements are required for efficient 
Sp1 transactivation depending on the promoter. For example, physical and functional 
interaction between the Sp1 and NF-Y transcription factors were previously reported to 
be involved in transcriptional activation of several genes (Liang et al., 2001; Yamada et 
al., 2000). 
 
1.4. Sp1 and the regulation of gene transcription 
 
Sp1 was one of the first eukaryotic transcription factors to be identified and cloned 
(Dynan and Tjian, 1983; Kadonaga et al., 1987). It has been shown to regulate a large 
number of genes by recognizing and binding GC-rich motifs. To date, it is well-known 
that Sp1 is a member of the Sp/XKLF family of transcription factors, and all members 
bind similar GC-rich sequences. A subfamily of Sp factors includes Sp1-Sp8, of which 
Sp1, Sp2, Sp3 and Sp4 contain similar structural modules. Unlike the rest of this 
subfamily, Sp1 and Sp3 are ubiquitously expressed (Bouwman et al., 2002).  
 
As a sequence-specific binding transcription factor, Sp1 has a DNA-binding domain that 
contains three contiguous Zinc fingers and four discrete functional domains that are 
responsible for transcriptional activation (See Fig. 1.3.). Activation domains A and B are 
glutamine rich, and each are flanked at their 5’ ends by a serine/threonine-rich region 











1999). In addition to playing a critical role in maintaining target gene expression, Sp1 
also exerts an important role in regulating gene expression (Samson and Wong, 2002). 
 
1.4.1. Sp1 cooperation with factors involved in transcriptional regulation 
 
Sp1 has been shown to bind a growing list of proteins involved in transcriptional 
regulation which suggests that it has diverse functions in gene regulation. These 
proteins include sequence-specific transcription factors as well as coactivators and 
corepressors which are discussed below. 
 
1.4.1.1. Sp1 interacts with sequence-specific transcription factors 
 
In addition to the CCAAT box binding protein NF-Y, a physical and functional co-
operation was also found in vitro between Sp1 and other proteins such as Ets1, USF 
and E2F1 (Gegonne et al., 1993; Lin et al., 1996; Ge et al., 2003 ). However, whether 
these complexes regulate specific genes in vivo remains to be elucidated.  
 
There is also evidence that Sp1 cooperates with Smads to induce the transcription of the 
Cdki p15ink4B in response to transforming growth factor-β (TGFβ). In this study, both the 
Sp1 site and the Smad-binding motif in the p15ink4B promoter were shown to be required 
for transactivation. Here, Smad3/4 directly associated with Sp1 which led to enhanced 
binding and transactivation of the p15ink4B promoter (Feng et al., 2000). Consistent with 
this finding, a similar regulatory mechanism was revealed in which Smad-mediated 
TGFβ upregulates p21 gene expression (Pardali et al., 2000).  
Interestingly, a previous report indicated that epidermal growth factor (EGF) induces 
expression of the human 12(S)-lipoxygenase gene in epidermoid carcinoma A431 cells 
by upregulating the activating protein 1 (AP1) component, c-Jun. However, no AP1 
binding site was found in the promoter region responsive to EGF and further 
investigations revealed that Sp1 acts as an anchor protein to recruit c-Jun to the 
promoter (Chen and Chang, 2000). Recent work by the same group also revealed that 
12-O-tetradecanoylphorbol-13-acetate (TPA) can enhance c-Jun/Sp1 interaction by 
Protein Phosphatase 2B-mediated dephosphorylation of c-Jun (Chen et al., 2007).  
Furthermore, interaction of v-Jun with Sp1/3 results in the inhibition of expression of the 























Figure 1.3.  Structural features of the Sp1 protein. A, B, C and D represent the four 
transactivation domains and the zinc finger DNA-binding domain with three zinc fingers 
are shown in dark blue. Two serine and threonine rich regions are represented by 






























1.4.1.2. Sp1 interaction with coactivators and corepressors of transcription 
 
In addition to interactions with sequence-specific transcription factors, Sp1 was also 
shown to exert an effect on transcription through interaction with transcriptional 
coactivators or corepressors. For example, the retinoblastoma protein (RB) was shown 
to directly associate with Sp1 in vivo, and to enhance transactivation of a Sp1-containing 
promoter (Udvadia et al., 1993). The coactivator p300 has also been shown to cooperate 
with Sp1 to regulate p21 promoter activity (Xiao et al., 2000). This was demonstrated to 
be due to the acetyltransferase region of p300 interacting with the DNA-binding domain 
of Sp1 and thereby increasing the DNA-binding activity of Sp1 (Suzuki et al., 2000). 
Moreover, ERK-mediated C-terminal phosphorylation of p300 enhances its association 
with Sp1 which is believed to be important for the regulation of EGF-induced keratin 16 
gene expression (Chen et al., 2007). 
Furthermore, Sp1 in association with either p107 or the nuclear orphan receptor EAR3 
represses the Luteinizing hormone receptor (LHR) gene in a Sp1 site dependent manner. 
The latter result was obtained in a study that demonstrated that EAR3 associates with 
Sp1 at the LHR promoter and that this interferes with the interaction between Sp1 and 
the general transcription factor TFIIB (Zhang and Dufau, 2003). Phosphorylation of Sp1 
however leads to its disassociation from p107 and the de-repression of the LHR gene 
promoter (Zhang et al., 2006). 
 
1.4.2. Sp1 as a sequence-specific transcription factor 
 
There is evidence that an increase in Sp1 protein levels in different cell systems leads to 
the upregulation in expression of several genes (Noe et al., 2001; D’Angelo et al., 1996; 
Pornttadavity et al., 2001; Sato and Furukawa, 2007). Current reports suggest that an 
interplay between Sp1 and other Sp proteins is involved in modulating cell-type-specific 
gene expression. Both Sp1 and Sp3 have similar affinities for GC-rich motifs and Sp3 
can compete with Sp1 to bind to the same GC-rich elements. Thus it is not difficult to 
imagine that an alteration in the Sp1/Sp3 ratio may affect transcriptional regulation of 
target genes. Indeed, Sp3 has been shown to activate or repress transcription 
depending on cell type and/or promoters. Its ability to repress transcription results from it 
preventing Sp1 from binding its target DNA (Samson and Wong, 2002). For example, in 











cyclooxygenase-2 which is thought to be due to an increase in Sp1 protein. In this 
experiment, Sp3 protein levels remain unchanged (Xu et al., 2000). In contrast, 
interleukin-1β down-regulates type II collagen gene expression in articular chrondrocytes 
because of an increase of the Sp3/Sp1 ratio (Chadjichristos et al., 2003). 
Similar to the interplay between Sp1 and Sp3, other transcription factors may also 
influence the ability of Sp1 to transactivate genes depending on the position of their 
binding sites. One example is Egr1 which has been shown to compete for binding to an 
overlapping motif in which both Sp1 and Egr1 can bind (Cao et al., 1993). 
 
1.4.3. Phosphorylation of Sp1  
 
Protein phosphorylation is one of the most common post-translational modifications 
involved in rapidly regulating transcription factor activity (Whitmarsh and Davis, 2000). 
Work by Jackson et al. in 1990 first revealed that Sp1 is phosphorylated by a DNA-
dependent protein kinase, but this phosphorylation has not been shown to affect the 
activity of Sp1. In recent years, a growing body of evidence has indicated that Sp1 
phosphorylation is not a constitutive modification but results from a variety of 
extracellular stimuli and a number of kinases, including PKC, PKA, DNA-PK, ERK, CK2 
and JNK. Phosphorylation of Sp1 has been shown to regulate its transcriptional activity, 
resulting in both positive and negative regulation of the expression of specific genes 
(Chu and Ferro, 2005; Samson and Wong, 2002; Chu and Ferro, 2006). 
Sp1 contains many potential phosphorylation sites with some being located in both its 
binding and transactivation domains. Thus, Sp1 can be phosphorylated at different sites 
or combinations of sites which may yield a different effect on Sp1 activity. Importantly, 
phorbol esters, well-known activators of PKC, up-regulate Sp1 mediated gene 
expression by phosphorylating Sp1 and consequently increasing its DNA binding activity 
in human HepG2 cells (Zheng et al., 2000). Similarly, atypical PKC-dependent 
phosphorylation of Sp1 leads to an increase in its DNA binding activity which is required 
for up-regulated platelet-derived growth factor B-chain gene expression (Rafty and 
Khachigian, 2001). ERK-mediated phosphorylation of Sp1 was also proposed to have an 
effect on its transcriptional activation of the endothelial growth factor gene in fibroblasts 
and Drosophila cells. The same investigators identified Thr453 and Thr739 as ERK 











phosphorylation of Sp1 was also shown to enhance Sp1 binding and transcriptional 
activity (Rohlff et al., 1997; Ahlgren et al., 1999).  
In contrast to the above scenario, Casein Kinase 2 (CK 2) phosphorylates Sp1 to lead to 
a decrease of Sp1 DNA binding activity in rat liver and K562 cells. In this case, CK2 
phosphorylates Sp1 on Thr579, which is in the second zinc finger in the DNA binding 
domain (Armstrong et al., 1997). Furthermore, loss of the reduced folate carrier (RFC) 
gene expression in antifolate-resistant leukemia cells is associated with an inhibitory Sp1 
phosphorylation (Stark and Assaraf, 2006). Interestingly, when aortic smooth muscle 
cells were treated with fibroblast growth factor-2, Sp1 was phosphorylated by ERK1/2 
which led to its increased DNA binding activity and repression of the platelet-derived 
growth factor receptor-alpha (Bonello and Khachigian, 2004). 
 
Although phosphorylation frequently affects the binding activity of Sp1, some cases have 
been reported where Sp1 phosphorylation was shown to influence transcriptional activity 
without altering its DNA binding activity. For example, Hepatocyte growth factor-induced 
phosphorylation of Sp1 in keratinocytes enhances its ability to activate the VEGF 
promoter without affecting its binding activity (Reisinger et al., 2003). Similarly, in 
endothelial cells, shear stress mediates Sp1-dependent activation of the tissue factor 
promoter, but shear stress-induced Sp1 phosphorylation does not change Sp1 binding 
activity (Lin et al., 1997). One possible mechanism by which phosphorylation of Sp1 may 
affect its transcriptional activity in this case may be to regulate its interaction with other 
transcription proteins as was shown for p107 above (Zhang et al., 2006). 
 
Protein phosphatases have also been shown to play an important role in Sp1 
phosphorylation status and hence regulation of Sp1 activity. There is evidence that 
treatment with the phosphatase inhibitor Okadaic acid leads to an increase in Sp1 
phosphorylation, and results in an increase or decrease Sp1 activity (Armstrong et al., 
1997; Daniel et al., 1996; Vlach et al., 1995; Wang et al., 1999; Ray et al., 1999;). 
Consistent with this finding, in vitro studies showed that Sp1 dephosphorylation with 
protein phosphatases also regulate Sp1 DNA binding activity (Rohlff et al., 1997; 
Chupreta et al., 2000; Stark and Assaraf, 2006; Wang et al., 1999; Armstrong et al., 












Finally, Sp1 phosphorylation has also been associated with organ development and cell 
proliferation. High levels of phosphorylated Sp1 were found in the mature liver and lung 
as compared to the developing liver and lung respectively (Chu et al., 1999; Leggett et 
al., 1995). In NIH/3T3 cells, dephosphorylation of Sp1 was observed when cell growth 
was induced by serum (Lacroix et al., 2002). Levels of phosphorylated Sp1 were also 
observed to be dynamic throughout the cell cycle (Leggett et al., 1995; Black et al., 
1999), and the cyclin-dependent kinase 2 (CDK2) has been suggested to be responsible 
for regulating this phosphorylation (Haidweger et al., 2001).  
 
1.4.4. Chromatin structure and Sp1 activity 
 
Transient modification of the chromatin structure is important in regulating transcription 
and a growing number of studies are now focussing on understanding this phenomenon. 
It is becoming clear that covalent modifications of histones play particularly critical roles 
in this process (discussed further in section 1.5.1). Compared to the various possible 
forms of histone modifications, acetylation is the best-understood. It is believed that 
acetylation results in reduced interaction between positively charged histone tails and 
negatively charged DNA, thus resulting in a relaxed chromatin structure which is more 
accessible to transcription factors. Deacetylation on the other hand is believed to result 
in chromatin condensation which restricts access of transcription factors to target DNA. 
Histone acetylation is controlled by histone acetyltransferases (HATs) and histone 
deacetylases (HDACs) (Grunstein, 1997; de Ruijter et al., 2003).  
 
Interestingly, Sp1 also plays a role in transcriptional regulation by chromatin remodeling. 
In mouse, Sp1 recruits HDAC1 to Sp1 sites in the HDAC1 promoter with a resultant 
repression of HDAC1 expression. This role of HDAC1 in the repression of its own 
promoter is emphasized by the observation that in the presence of the deacetylase 
inhibitor trichostatin A (TSA) the same Sp1 sites are essential for activation of the 
HDAC1 promoter. These results suggest that there is an autoregulatory mechanism 
controlling HDAC1 expression in mammalian cells (Schuettengruber et al., 2003; 
Doetzlhofer et al., 1999). Additional support for a negative role of histone acetylation in 
transcription was demonstrated in studies which showed that TSA induced human 
telomerase reverse transcriptase (hTERT) expression in normal cells, and activates the 











studies in Hela cells, HDAC inhibitors were also shown to activate p21 transcription 
through a Sp1 site (Han et al., 2001). Finally, OX40, a member of the TNFR superfamily 
is expressed on activated T cells and regulates T cell-mediated immune responses. It 
was recently demonstrated that up-regulation of OX40 gene expression involves a 
mechanism of chromatin remodeling requiring a Sp1 site in the OX40 promoter (Tone et 
al., 2007). 
 
As illustrated above, the role of Sp1 in regulating gene expression is complex and 
involves diverse mechanisms such as post-translational modification, protein-protein 
interaction, and alteration of chromatin structure. 
  
1.5. Histone H3 phosphorylation and gene transcriptional activation 
 
1.5.1. Structure and function of the nucleosome 
 
In eukaryotic cells, the enormous length of genomic DNA must be packaged into a highly 
ordered and condensed structure called chromatin in order to fit within cells. The basic 
building unit of chromatin is the nucleosome which consists of a protein core with 146 
base pairs of DNA wound around it (Fig. 1.4.). The protein core is an octamer containing 
two copies each of histones H2A, H2B, H3 and H4. These core histones have a similar 
structure with a basic N-terminal domain, a globular domain and a C-terminal tail. The 
histone-fold domains of the four core histones are responsible for histone-histone and 
histone-DNA interactions (Luger et al., 1997).  
N-terminal tails of histones protrude outside of the nucleosomes and are subject to a 
variety of covalent post-translational modifications, including acetylation, phosphorylation, 
methylation, ubiquitination and ADP-ribosylation. These modifications are generally 
transient and dynamic and result in alteration of chromatin configuration (Nowak and 
Corces, 2004) (Fig. 1.5.), which in turn may affect access of transcription factors to their 
target promoters and hence gene expression.  For example, phosphorylation of the N-
terminal tail of histone H3 has been linked to transcriptional activation of the c-fos and c-
jun immediate-early (IE) response genes (Mahadevan et al., 1991). Phosphorylation of 
histone H3 on serine 10 was first observed in association with chromosomal 























Figure 1.5. Post-translational modification of the histone H3 N-terminal tail domain. The 
potential sites of the covalent modifications, acetylation, phosphorylation and 
methylation, are indicated and the cellular processes affected are shown on the left 
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1.5.2. Histone H3 phosphorylation during mitosis 
 
Histone H3 phosphorylation at Ser10 was found to be associated with chromosome 
condensation and segregation during mitosis and has hence been regarded as a marker 
of mitosis. The pattern of mitotic histone H3-Ser10 phosphyorylation was shown to be 
global (Gurley et al., 1978; Hendzel et al., 1997; Johansen, 2006); begining in pericentric 
heterochromatin during G2 phase, becoming widespread by prophase, and persisting to 
telophase (Gurley et al., 1978; Hendzel et al., 1997). In addition, Ser28 phosphorylation 
of histone H3 was also identified as another mitotic marker. Members of the Aurora 
kinase family have been suggested to be responsible for this phosphorylation of Ser10 
and Ser28 in histone H3 during mitosis (Johansen, 2006). 
 
1.5.3. Histone H3 phosphorylation during transcriptional activation 
 
In 1991, pioneering work by Mahadevan and colleagues revealed a close correlation 
between phosphorylation of histone H3-Ser10 and induction of IE genes such as c-jun 
and c-fos in response to growth factors and phorbol esters in mouse fibroblast cells. 
These findings led the authors to postulate that a link exists between the 
phosphorylation of histone H3-Ser10 and transcriptional activation (Mahadevan et al., 
1991). Thus, phosphorylation of histone H3 is associated not only with mitosis but also 
with the activation of gene expression. This raises the question of its role in these 
processes which involve such different chromatin states. To date, it is well known that 
stimulus-mediated phosphorylation of histone H3 is transient and that it affects only a 
small fraction of total histone H3 protein. This is different to the situation observed during 
mitosis where the majority of histone H3 is phosphorylated (Clayton and Mahadevan, 
2003; Johansen, 2006). Several kinases have been suggested to be responsible for 
phosphorylating histone H3 at Ser10 and Ser28 in association with gene expression and 
will be discussed under section 1.5.4.  
 
Further evidence supporting the role of histone H3-Ser10 phosphorylation in the 
induction of gene expression has been obtained from several studies as detailed in the 
following examples. Firstly, phosphorylation of histone H3-Ser10 has been found to 
occur at transcriptionally active heat shock loci in Drosophila larval salivary glands 
(Nowak and Corces, 2000). Secondly, treatment of mouse ovarian granulosa cells by 











potential role in the transcription of genes required for the establishment of a cellular 
differentiation program (DeManno et al., 1999). Stimuli-induced phosphorylation of 
histone H3 at Ser10 was also found in certain neuronal cells and correlated with IE gene 
expression (Crosio et al., 2000; Brami-Cherrier et al., 2007). In addition to early genes, 
transcriptional activation of several “late” inducible genes was also shown to be 
associated with phosphorylation of histone H3. These include IL-2-mediated HDAC1 
expression in mouse B6.1 cells (Hauser et al., 2002) and expression of telomerase 
reverse transcriptase in response to mitogens and stress in human T cells and 
fibroblasts (Ge et al., 2006). Thus, phosphorylation of histone H3-Ser10 has been 
implicated in the expression of a number of stimulus-induced genes and an increasing 
number of genes regulated in this way continue to be identified.  
 
In addition to Ser10, stimulation by mitogens and stress also cause phosphorylation of 
histone H3 at Ser28. One study using antibodies specific to phosphorylated histone H3-
Ser10 and H3-Ser28 demonstrated that phosphorylation of Ser10 and Ser28 occur 
separately on different H3 tails and are even associated with different chromatin 
fragments. Unlike the case for H3-Ser10, there is very little association between 
phosphorylation of H3-Ser28 and stimuli-induced IE genes in mouse fibroblasts (Dyson 
et al., 2003). Whether there are target genes regulated by phosphorylation of histone 
H3-Ser28 remains to be elucidated. 
 
There is conflicting information in the literature regarding whether there is a synergistic 
role between acetylation and phosphorylation of histone H3. A number of reports have 
shown that both phosphorylation and acetylation occur on induced genes (Clayton and 
Mahadevan, 2003). Moreover, acetylation and phosphorylation have been shown to 
coexist in the same histone H3 tail (Cheung et al., 2000; Clayton et al., 2000). Support 
for a synergistic role between phosphorylation and acetylation of histone H3 comes from 
a study which showed that mouse fibroblasts stimulated with EGF resulted in both 
phosphorylation and acetylation of the c-fos gene (Cheung et al., 2000). There is also 
evidence that phosphorylation/acetylation (Ser10/Lys14) of histone H3 is necessary for 
the recruitment of general transcription factors (Agalioti et al., 2002).   
 
Several lines of evidence have also suggested that phosphorylation and acetylation are 











synergy between the two protein modifications (Clayton and Mahadevan, 2003). This 
possibility is supported by observations that only histone H3 phosphorylation occurs at 
transcriptionally active heat shock loci (Nowak and Corces, 2000) and that glutamate 
induces histone H3 phosphorylation but not acetylation in striatal neurons (Brami-
Cherrier et al., 2007). It seems likely, that while on the one hand, both acetylation and 
phosphorylation are required for sufficient transcriptional activation of some genes, on 
the other hand, transcriptional activation of other genes are associated with 
phosphorylation of H3 but independent of acetylation.  
 
1.5.4. Cell signalling pathways and kinases regulating histone H3 
phosphorylation  
 
Several cell signalling pathways have been implicated in the phosphorylation of histone 
H3 in response to a variety of stimuli but the mitogen-activated protein (MAP) kinase 
signalling pathways are the best understood.  
 
The MAP kinases represent one of the most important and well characterised families of 
kinases, which catalyse the phosphorylation of a wide range of substrates in response to 
diverse stimuli (Robinson and Cobb, 1997). The MAP kinase family is divided into four 
distinct subgroups: the extracellular signal-regulated kinases (ERKs), c-jun N-terminal or 
stress-activated protein kinases (JNK/SAPK), ERK5/big MAP kinase 1 (BMK1) and the 
p38 group of protein kinases. ERK family members are mainly activated by mitogenic 
stimuli, while the JNK and p38 MAP kinases are activated mainly in response to stress 
stimuli or inflammatory cytokines (Roux and Blenis, 2004; Kyriakis and Avruch, 2001). 
The recently identified subgroup, ERK5, is activated by a combination of mitogenic 
stimuli and osmotic stress (Wang and Tournier, 2006). MAP kinases are activated via a 
highly conserved phospho-relay system composed of three sequentially activated 
protein kinases. The first kinase in this cascade is the MAP kinase kinase kinase 
(MAPKKK) which, in response to a specific stimulus, phosphorylates and activates the 
dual-specificity MAP kinase kinase (MAPKK) at specific serine/threonine residues. 
MAPKK in turn phosphorylates MAP kinase at threonine and tyrosine residues within the 
Thr-Xaa-Tyr motif, which is essential for complete activation of the MAP kinase. Once 











target proteins, many of which are transcription factors, cytoplasmic substrates and other 
kinases (Robinson and Cobb, 1997; Garrington and Johnson, 1999).  
 
Mitogen- and stress- induced phosphorylation of histone H3 has been demonstrated to 
be mediated by the Erk and/or p38 MAPK cascades in many different systems. There is 
however no evidence showing that phosphorylation of histone H3 is mediated by the 
JNK signalling pathway in response to stimuli (Clayton and Mahadevan, 2003). However, 
a recent study showed that SP600125, a small molecule inhibitor of JNK, reduced global 
histone H3-Ser10 phosphorylation in human hepatocellular HepG2 cells. Interestingly, 
the authors found SP600125-dependent hypophosphorylation of histone H3-Ser10 to be 
independent of MAPKs (Huang et al., 2006). This would suggest that either the 
SP600125 JNK inhibitor is not specific to JNK or that there are circumstances under 
which JNK can phosphorylate histone H3.  
 
There are several kinases that have been proposed to phosphorylate histone H3 in 
response to mitogens or stress. These include mitogen- and stress-activated kinase 1/2 
(MSK1/2) and ribosomal S6 kinase 2 (RSK2). Current evidence suggests that MSK1 and 
2 are primary histone 3 kinases (Clayton and Mahadevan, 2003). Both MSK1 and 2 are 
located in the nucleus and are activated by either ERK1/2 or p38. MSK1 has been 
shown to activate histone H3 in vitro, and an inhibitor of MSK blocks the nucleosomal 
response in vivo (Thomson et al., 1999). Furthermore, mitogens and stress have a 
severely reduced or no effect on histone H3 phosphorylation in MSK1/2 knockout mice 
(Soloaga et al., 2003).   
 
Protein Kinase C (PKC) is a major intracellular target of TPA and it is well established 
that in response to TPA, PKCs can activate the Ras/Raf/MEK/ERK MAPK pathway. PKC 
represents an important multigene family of serine/threonine kinases that can be 
activated by various extracellular and intracellular signals and have been involved in 
broad and diverse functions in many physiological and pathological processes (Mellor 
and Parker, 1998; Newton et al., 1997; Griner and Kazanietz, 2007 ). The PKC family 
comprises at least 12 isoforms that are divided into three subfamilies: conventional or 
classical PKCs (cPKCs; α, β 1/2 and γ), novel PKCs (nPKCs; δ, ε, η, and θ), and 




















Figure 1.6.  Schematic representation of the cell signalling pathways leading to histone 
H3 phosphorylation. Two well-established MAKP signalling pathways, ERK and p38, 
mediate histone H3 phosphorylatiion by activation of MSK1/2 in response to mitogens, 
growth factors, stress and cytokines. The IKK-α is responsible for phosphorylating 
histone H3 in cytokine-induced activation of NF-KB transcription. PKC may also act as a 
































TPA can activate p38 and JNK in a cell-type dependent manner (Lόpez-Bergami et al., 
2005; Mauro et al., 2002). Moreover, phorbol esters have also been shown to induce 
histone H3-Ser10 phosphorylation at the LDL receptor promoter in a protein kinase C-
dependent manner (Huang et al., 2004).  
 
It is worth noting that cytokines induce the expression of several NF-kB-dependent 
genes via activation of the NF-kB pathway. IkB kinase α (IKK-α), a downstream 
component of this pathway, has been suggested to play a role in phosphorylating 
histone H3 (Yamamoto et al., 2003; Anest et al., 2003). Protein kinase A (PKA) also 
mediates phosphorylation of histone H3-Ser10 in rat ovarian granulose cells treated with 
FSH (DeManno et al., 1999) (Fig. 1.6.). 
 
As described above, phosphorylation of histone H3 has been associated with the 
regulation of gene expresson, and several signalling pathways have been identified that 
mediate H3 phosphorylation. However, stimulus-induced histone H3 phosphorylation is 
not sufficient for the induction of expression of some genes and thus, phosphorylation of 
H3 may cooperate with other molecular mechanisms that regulate genes such as 
transcription factor phosphorylation. 
 
 
1.6 General and specific aims of study 
 
Tbx2 has been implicated in several developmental processes such as coordinating cell 
fate, patterning and morphogenesis of a wide range of tissues and organs. Furthermore, 
Tbx2 is also emerging as a key regulator of the cell cycle and dosage sensitivity of this 
gene has been implicated in several cancers. However very little is also known about the 
signalling pathways regulating the expression and activity of Tbx2. While its role as a 
transcriptional repressor is well defined there is limited information regarding its target 
genes. Identifying Tbx2 target genes as well as signalling pathways that regulate the 
activity of Tbx2 is imperative to understanding its oncogenic role and may provide 
important targets for cancer treatments.The general aim of this project is therefore to 
explore the ability of Tbx2 to regulate the type 1 collagen gene and to investigate 













1. To investigate the regulation of type 1 collagen gene expression by Tbx2. 
2. To clone the human Tbx2 regulatory region and to identify cis-acting elements 
involved in the basal transcription of the Tbx2 gene. 









































CHAPTER  2 
 
A ROLE FOR TBX2 IN THE REGULATION OF THE 2(1) COLLAGEN GENE 
IN HUMAN FIBROBLASTS 
 
2.1. Introduction 
Recent studies have implicated the mouse type 1 collagen gene as a potential Tbx2 
target (Chen et al., 2001). Type I collagen synthesis is crucial for normal embryonic 
development and in maintaining tissue integrity and its aberrant expression has 
deleterious effects on several biological processes (Bornstein and Sage, 1989). Mice 
lacking the α1(I) collagen gene for example, display defective angioge esis (Lohhler et 
al., 1984), while in humans, dominant negative mutations in any of the type I collagen 
genes result in diseases such as osteogenesis imperfecta and Ehlers Danlos syndrome 
(Kuivaniemi et al., 1991; Prockop et al., 1993, 1994). Abnormal collagen synthesis is 
also associated with diseases such as arthritis, fibrosis and with tumour cell invasion and 
metastasis (Fenhalls et al., 1999; Fusenig et al., 2004). In an attempt to identify genes 
that may be regulated by Tbx2, DNA microarray analysis was performed on mouse 
NIH3T3 fibroblasts overexpressing Tbx2 and the results revealed that the type 1 
collagen gene was upregulated (Chen et al., 2001). Interestingly, a parallel investigation 
in which Tbx2 was overexpressed in the rat ROS17/2.8 osteoblastic cell line showed 
down-regulation of type I collagen (Chen et al., 2001). While this study suggests that 
Tbx2 may function as both activator and repressor, the data does not address whether 
Tbx2 directly mediates the transcriptional effect on the type 1 collagen gene. However, 
these contrasting results do suggest that the cell context and/or the species may be 
important in determining the effect of Tbx2 on the expression of the type I collagen 
genes.  
 
The aim of this chapter was therefore to investigate the regulation of type 1 collagen 
gene expression by Tbx2. Our findings show that there is a correlation between the 
expression patterns of endogenous Tbx2 and COL1A2 in several human fibroblast cell 
lines and provide compelling evidence that Tbx2 represses expression of the human 
COL1A2 gene. This study suggests that Tbx2 is involved in the regulation of the human 
COL1A2 gene which has important implications for our understanding of the role of Tbx2 











2.2. Results  
 
2.2.1. Correlation between TBX2 and COL1A2 expression patterns in fibroblast cell   
          lines 
 
To determine whether Tbx2 can regulate collagen gene expression we firstly 
investigated whether TBX2 was expressed in normal and transformed fibroblast cell 
lines. The results of western blot analyses (Fig. 2.1A) show that TBX2 was expressed at 
high levels in the normal WI-38 fibroblast cell line, was dramatically reduced in WI-38 
cells transformed by exposure to cobalt radiation (CT-1) and was almost undetectable in 
the SV40-transformed WI-38 cells (SVWI-38) and in human fibrosarcoma cells (HT1080). 
Interestingly, this pattern of TBX2 expression followed the same trend as that obtained 
for COL1A2 mRNA (Fig. 2.1B). This direct correlation initially suggested that Tbx2 may 
play a role in activating the human COL1A2 promoter. 
 
2.2.2. Overexpression of TBX2 reduces COL1A2 mRNA levels 
 
To determine whether Tbx2 regulates endogenous COL1A2 gene expression, we 
established CT-1 and HT1080 cell lines that stably express exogenous Tbx2. The CT-1 
cell line was selected because it had reduced Tbx2 protein levels and reduced COL1A2 
mRNA compared to the normal parental WI-38 cells. The HT1080 cell line, on the other 
hand, was chosen to determine whether the introduction of Tbx2 would be sufficient to 
induce COL1A2 gene expression because it lacked detectable levels of COL1A2 mRNA. 
A number of G418-resistant clones were tested for TBX2 expression. Figure 2.2.A 
shows the presence of Tbx2 protein in representative clones (CT-Tbx2(2), CT-Tbx2(3), 
HT-Tbx2(5) and HT-Tbx2(6)) that is undetectable in cells transfected with the empty 
vector (CT-E and HT-E). This result was confirmed by immunocytochemistry (Fig. 2.2.B) 
where predominant staining was seen in the nuclei of CT-Tbx2 and HT-Tbx2 cell lines 
while low levels were detected in CT-E cells and no immunostaining was observed in the 
control HT1080 cell line harboring empty vector pcDNA (data not shown). We selected 
the CT-Tbx2(2), CT-Tbx2(3), HT-Tbx2(5) and HT-Tbx2(6) cell lines to investigate the 
effect of Tbx2 on endogenous COL1A2 using qRT-PCR.  Our results, shown in Figure 
2.2.C, indicate that the COL1A2 mRNA levels were repressed by approximately 2 fold in 











overexpression of Tbx2 leads to downregulation of COL1A2 gene expression. These 
results confirmed that the COL1A2 gene is repressed independently of Tbx2 in the 
HT1080 cells. Taken together these results raised the question of whether Tbx2 was 
able to directly regulate expression of the COL1A2 gene. 
 
2.2.3. Tbx2 represses COL1A2 promoter activity 
 
Tbx2 has been shown to regulate target gene expression by binding the consensus T-
box binding site GTGTGA as well as the GTGTTA and GGGTGA sequences. We 
therefore screened the 5’ upstream regulatory region of the human α2(I) collagen gene 
for these sites and located a GTGTGA sequence at position -1400. To determine 
whether Tbx2 downregulates the COL1A2 gene directly through this site, we performed 
transient transfection assays using a luciferase reporter driven by 5’ deletion constructs 
of the human COL1A2 gene promoter (Fig. 2.3.A). HT1080 cells were initially used in 
these assays because they do not have detectable levels of endogenous Tbx2 protein or 
collagen mRNA. The transfection data showed that wild-type Tbx2 acts as a strong 
dose-dependent repressor of the COL1A2 promoter (Fig. 2.3.B). All four human COL1A2 
promoter-deletion constructs tested appear to be strongly repressed by Tbx2 suggesting 
that Tbx2 acts through an element located in the region -107 to +50 of the human 
COL1A2 promoter and not through the putative binding site at position -1400. Similar 
results were obtained in CT-1 cells that have detectable levels of COL1A2 mRNA and 
Tbx2 protein (Fig. 2.3.C). Further investigation of the Tbx2 response element by deletion 

















Figure 2.1. Tbx2 protein and COL1A2 mRNA exhibit similar patterns of expression in 
normal and transformed human fibroblast cell lines. (A) Western blot analyses were 
used to compare the relative levels of Tbx2 protein in normal embryonic lung fibroblasts 
(WI-38 cell line), two of its transformed counterparts (SVWI-38 and CT-1) and a naturally 
occurring fibrosarcoma cell line (HT1080). Protein blots were probed with antibodies 
specific for Tbx2 and tubulin and detected by enhanced chemiluminescence as 
described in Materials and methods. * indicate a short exposure of the blot. (B) Northern 
blot analyses, using total RNA (5μg) from cell lines described in (A) were used to 































Figure 2.2. See overleaf for legend 
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Figure 2.2. Tbx2 represses endogenous COL1A2. CT-E, CT-Tbx2, HT-E and HT-Tbx2 
cell lines were established by stable transfection of CT-1 and HT1080 cells with either an 
empty vector or a TBX2-expression plasmid followed by G418 selection. (A) Western 
blot and (B) Immunohistochemical analyses were used to confirm that the CT-Tbx2 and 
HT-Tbx2 cell lines express readily detectable levels of Tbx2 protein. Both tubulin and 
total p38 levels were used as loading controls as similar studies have shown that both 
markers give comparable results. (C) Quantitative real-time PCR was performed to 
establish the effect of stably expressing TBX2 on COL1A2 in CT-1 and HT-1080 cells.   
(C) Total RNA was extracted from CT-1, CT-E, CT-Tbx2(2), CT-Tbx2(3), HT-E, HT-
Tbx2(5) and HT-Tbx2(6). Quantitative real-time PCR was then performed on reverse 


















Figure 2.3. Tbx2 represses COL1A2 promoter activity. (A) Schematic representation of 
COL1A2 5’ deletion constructs generated by restriction enzyme digestion. The arrow 
indicates the transcription start site at +1 and the * indicates the putative Tbx2 binding 
site (GTGTGA) at -1400. The plasmids containing sequentially deleted fragments of p(-
2300)Luc were transiently transfected into the HT1080 (B) and CT-1 (C) cell lines 
together with increasing amounts of the Tbx2 expression plasmid pCMV-Tbx2. Total 
amount of plasmid DNA transfected was held constant using the corresponding empty 
vector, pCMV. The plasmid pRL-TK containing the Renilla luciferase reporter gene was 
also introduced to normalize transfection efficiency. Promoter activity is indicated as fold 
repression which represents the ratio of the luciferase activity generated by the pCMV 


















Type I collagen is the most abundant protein in nature and plays a very important role 
during development as it is the basic component of skin, cartilage, bone and connective 
tissue (Kadler et al., 1996). Appropriate regulation of expression of the Type I collagen 
gene is therefore crucial. The transcription factor, Tbx2, is essential for normal 
embryonic development, most probably by regulating the expression of developmentally 
important genes such as those that encode the collagens. Although the expression 
patterns of Tbx2 during development have been widely studied, only a few of its target 
genes have been identified to date (Carreira et al., 1998; Chen et al., 2001; Jacobs et al., 
2000; Prince et al., 2004). This study shows that TBX2 is expressed in human lung 
fibroblasts and is downregulated in transformed fibroblasts in a manner which mimics 
the expression pattern for the COL1A2 gene. This initial observation suggested that 
Tbx2 may be acting as a positive regulator of the COL1A2 gene. However, further 
investigations showed that Tbx2 is in fact a negative regulator of the COL1A2 gene and 
that it is able to repress its expression in the absence of the published consensus T-
element. This result is consistent with that obtained by Jacobs et al. (2000) who also 
found that Tbx2 was able to repress the p19ARF promoter in the absence of a putative T-
box binding site. Taken together, these results suggest that Tbx2 may be functioning as 
a co-repressor of the COL1A2 gene which is in keeping with the suggestion that the 
target specificity of T-box family members depends on their association with different 
cofactors. Thus, an important research approach would be to investigate proteins which 
may interact with Tbx2 by, for example, the yeast two-hybrid screen assay. It is of 
course also possible that the effect seen on COL1A2 is due to the repression by Tbx2 of 
a COL1A2 activator. 
 
The involvement of Tbx2 in tumourigenesis is poorly defined and it is not clear whether it 
is involved in the initiation, progression and/or metastasis of cancer. Tumour invasion 
and metastasis require breakdown of collagen and a reduction in collagen production 
(Christner et al., 2006; Liotta et al., 1979; Tanjore and Kalluri, 2006). It would be 
important to clarify whether the ability of Tbx2 to repress COL1A2 has any significance 
in these processes. We cannot, however, rule out the possibility that the repression of 
the endogenous COL1A2 gene in the CT-Tbx2 cell lines may have resulted from other 











luciferase assays would however suggest that at the very least Tbx2 is able to directly 
regulate the expression of this gene as a co-repressor. Identifying candidate Tbx2 
accessory proteins involved in regulating COL1A2 gene expression may provide 
important clues as to the precise mechanism by which Tbx2 regulates this important 
gene.  
 
Having identified COL1A2 as a Tbx2 target gene, we next investigated the regulation of 
the TBX2 gene by identifying cis-acting elements important for TBX2 expression as well 



























2.4.   Materials and methods 
 
2.4.1. Cell Culture  
 
 Human embryonic lung fibroblast WI-38 cells (ATCC CCL-75), SV40 transformed WI-38 
fibroblast cells (SVWI-38) (de Haan et al., 1986), -radiation transformed WI-38 fibroblast 
cells (CT-1) (Namba et al., 1980) and human fibrosarcoma cells HT1080 (HT) (ATCC 
CCL-120) cells were cultured in Dulbecco’s modified Eagle’s medium (DMEM) 
supplemented with 10% fetal bovine serum, 100 units/ml penicillin and 100g/ml 
streptomycin at 37ºC in an atmosphere of  5% CO2. 
 
2.4.2. Generation of Stable Cell Lines Expressing Tbx2 
 
To generate stably transfected cell lines, CT-1 and HT1080 cells were seeded in 
duplicate in 60-mm dishes at a density of 3.2 X 105 cells per dish 24 h before 
transfection. Cells were transfected with either the empty expression vector pcDNA3.1 (+) 
or with this vector containing the full length human Tbx2 cDNA (Lingbeek et al., 2002) 
using the standard calcium-phosphate precipitation method. Transfected cells were 
allowed to recover for 48 h and CT-1 and HT1080 transfectants were selected in 
medium containing 400 g/ml and 800 μg/ml G418 respectively. Colonies were 
subcloned and selected based on positive Tbx2 immunoreactivity in the case of 
pcDNA3.1-Tbx2 transfectants. Among subcloned cell lines, two from both the CT-1 and 
HT1080 cell lines were chosen for subsequent analysis. CT-Tbx2 and HT-Tbx2 
contained the pcDNA3.1-Tbx2 construct while CT-E and HT-E contained pcDNA3.1 
empty vector. 
 
2.4.3. Plasmid Constructs 
 
The human COL1A2 promoter luciferase reporters were generated by inserting the 
EcoRV(-2389)-Hind III(+58), Xho 1(-721)-Hind III (+58), Bgl II (-375)-Hind III (+58) and 
Sma I (-107)-Hind III (+58) fragments of the COL1A2 gene (Parker et al., 1992) into the 
appropriately cleaved luciferase reporter vector pRL-CMV-basic (Promega, USA). The 











transfection efficiency. The pcDNA3.1-Tbx2 expression vector was kindly provided by Dr. 
Merel Lingbeek (Lingbeek et al., 2002) 
 
2.4.4. Transient Transfection Assay 
 
Cells were plated at 1.5 x 105 cells/ml in six-well plates 1 day before transfection. Non-
liposomal mediated gene transfer was performed using FuGENE®6 (Roche Applied 
Science) according to manufacturer’s instructions using 1 g of DNA consisting of the 
reporter construct, the Tbx2 expression vector and the internal control vector. Thirty 
hours after transfection, cells were analyzed for luciferase activity using the Dual-
Luciferase Reporter Assay (Promega, USA) following manufacturer’s instructions and 
quantified with a Luminoskan Ascent Luminometer (Thermo LabSystems, USA).  
 
2.4.5. Western blot analyses 
 
Cells were harvested and solubilized at 4oC with lysis buffer (40 mM Tris-HCl, 150 mM 
NaCl, 0.5% Sodium Deoxycholate, 1% Nonidet P40, 0.1% SDS and protease inhibitors), 
incubated on ice for 30 minutes and centrifuged at 12000 rpm for 20 minutes at 4oC. 
Protein concentrations in lysates were determined using the BCA (bicinchoninic acid) 
protein assay kit (Pierce, Rockford, IL, USA) with bovine serum albumin as the standard. 
Twenty micrograms of protein extract were separated on a 10% SDS-PAGE gel and 
then transferred onto nitrocellulose Hybond-C membrane (Amersham, USA). Following 
blocking for 1 hour at room temperature, the membranes were probed with mouse 
monoclonal anti-Tbx2 primary antibody (62-2; 1:2500). Immunoreactive bands were 
visualized with a horseradish peroxidase-conjugated secondary goat anti-mouse serum 
(1:4000) (Biorad, USA) and detected with enhanced chemiluminescence (ECL) (Pierce, 
USA). Monoclonal mouse anti--tubulin (1:500, Santa Cruz Biotechnology, USA) and 
rabbit polyclonal anti-p38 (1:5000, Cell Signalling Technology Inc., Beverly, MA) primary 















2.4.6. Northern blot analyses 
 
Total RNA was extracted from cultured cells using Trizol reagent (Life Technologies, 
USA). RNA concentration was determined by spectrophotometric absorbance at 260 nm, 
and 5 g was separated by electrophoresis in 1% formaldehyde-agarose gels. Gels 
were then transferred by capillary action to nylon membranes (Amersham, USA). 
Membranes were probed with random-primed 32P-radiolabeled (Amersham, USA) 
Col1A2 and -actin cDNA fragments. Hybridization was carried out in the ULTRAhyb 




Cells grown on glass coverslips were fixed in 4% paraformaldehyde at room temperature 
for 20 min and permeabilized in 0.2% Triton X-100 in phosphate buffered saline (PBS) 
for 10 min. Cells were incubated overnight with mouse Tbx2 monoclonal antibody (62-2) 
at a dilution of 1:750 and then incubated with the appropriate secondary antibody 
coupled to alexa 488 (Molecular Probes, USA) at a 1:1000 dilution. Cells were incubated 
in the dark with 1 μg/ml DAPI in PBS for 10 min, mounted on a slide and visualized by 
fluorescence microscopy.  
 
2.4.8. Real time RT PCR 
 
Total cellular RNA was extracted as described for northern blot analyses. Reverse 
transcription was carried out using Superscript III Reverse Transcriptase (Invitrogen), 
with oligo(dT)20 primers. PCR was conducted using 2 μl of a 1 in 10 dilution of the cDNA 
and primers (COL1A2: forward 5’-GATTGAGACCCTTCTTACTCCTGAA-3’; reverse 5’-
GGGTGGCTGAGTCTCAAGTCA-3’; Glyceraldehyde-3-phosphate dehydrogenase 
(GAPDH): forward 5’-GAAGGCTGGGGCTCATTT-3’; reverse 5’-
CAGGAGGCATTGCTGATGAT-3’) with LightCycler FastStart DNA MasterPLUS SYBR 
green 1 kit (Roche) according to the manufacturer’s protocol. Real-time PCR was carried 
out on a LightCycler Version 3 (Roche) with the following protocol: 95°C for 10 min; and 
45 cycles of 95°C for 10 seconds (denaturation), 55°C for 5 seconds (annealing), and 











DNA sample was quantified in duplicate and a negative control without cDNA 
template was run with every assay to assess the overall specificity. Melting curve 
analyses was carried out to ensure product specificity and data was analysed 
using the 2-ΔΔCt method. COL1A2 mRNA levels were normalized to GAPDH with PCR 
efficiency correction calculated using the formula Ratio = (Etarget)CPtarget(control – 






























CLONING OF THE 5’ REGULATORY REGION OF THE HUMAN TBX2 GENE 
AND FUNCTIONAL CHARACTERIZATION OF CIS-ACTING ELEMENTS 




Elucidating the mechanisms regulating Tbx2 expression is of importance for 
understanding the precise roles of Tbx2 in physiological and pathological processes. It is 
thus surprising that to date relatively little is known about the transcriptional regulation of 
the Tbx2 gene. 
 
The 5’-flanking region of the mouse Tbx2 gene has been cloned and the transcription 
factor Mitf was shown to activate Tbx2 gene expression by recognizing an E-box 
element in melanocytes (Carreira et al., 2000). A putative retinoic acid response element 
was also identified in this promoter and it was shown to be responsible for retinoic acid 
stimulated Tbx2 gene expression (Boskovic and Niles, 2004). A recent study showed 
that Tbx20 was able to bind in vivo to a 5’-flanking regulatory region of the mouse Tbx2 
gene which contains a putative T-element. This finding suggested that Tbx2 is a direct 
target for repression by Tbx20 in the developing heart (Cai et al., 2005). However, 
important cis-acting elements responsible for Tbx2 gene expression have not yet been 
identified, and relatively few studies have reported on the regulation of the human TBX2 
gene.  
 
To better understand the molecular mechanisms regulating Tbx2 gene expression, one 
of the aims of this study was to clone and characterize the 5’-regulatory region of the 
TBX2 gene and the details are described in this chapter. Having successfully cloned a 
5’-flanking region of the TBX2 gene from the human WI-38 fibroblasts, we show that the 
proximal promoter (-216/+32) mediates most of the basal activity and that a proximal 
Sp1 site juxtaposed to an inverted CCAAT box element are both essential for basal 
promoter activity. While a physical and functional interaction between Sp1 and the 
CCAAT box binding protein NF-Y was not essential for optimal basal promoter activity, a 
dynamic balance in their levels appears to be important. Furthermore, our data reveal a 
potential downstream promoter element (DPE) in the TBX2 promoter which significantly 













3.2.1. Cloning and functional analysis of the 5’- regulatory region of the TBX2   
          gene 
 
To identify potential cis-acting elements required for basal TBX2 gene activity, a 1638 bp 
DNA fragment from -1606 to +32, relative to a putative transcriptional start site was 
cloned (Fig. 3.1.A). The whole sequence was verified by sequencing (see appendix 1) 
and confirmed by alignment with the human genomic DNA database. A 98% nucleotide 
identity was observed between the -216 to +32 region of the human TBX2 gene and the 
mouse Tbx2 proximal promoter (Fig. 3.1.B). 
 
To define the region essential for basal transcription of the TBX2 gene, a series of 5’-
deletion luciferase reporter constructs were prepared using restriction enzymes as 
shown in Fig. 3.1.A.  Functional analysis of these constructs showed that a proximal 
promoter (-216/+32) maintains high levels of basal activity (Fig. 3.1.C). This together 
with the observation that this region shares a very high degree of homology with the 
mouse Tbx2 proximal promoter suggested that it will contained important cis-acting 
elements. We, therefore, used the TFSEARCH program 
(www.cbrc.jp/research/db/TFSEARCH.html) to search for potential cis-acting elements in 
this proximal promoter and putative regulatory elements are shown in Fig. 3.1.B. To 
determine whether these putative elements were responsible for basal activity of the 
TBX2 gene, mutant constructs for each of the putative sites were generated and 
luciferase activity assays were carried out. Whereas individual mutations in the Sp1 and 
CCAAT box sites resulted in a 6.7-fold and a 4.6-fold decrease of luciferase activity 
respectively, mutating both sites resulted in a 13.5-fold reduction (Fig. 3.1.D). Mutating 
the other putative sites individually did not significantly affect basal promoter activity (see 
appendix 4).      
 
3.2.2. Sp1 and NF-Y bind the Sp1 and CCAAT box motifs respectively  
          identified in the TBX2 proximal promoter  
 
The ubiquitously expressed Sp1 and NF-Y transcription factors are potentially able to 
regulate the proximal TBX2 promoter through binding the identified Sp1 and CCAAT box 











results indicated that nuclear factors bound to radiolabelled oligonucleotides which 
contain either only the wild type CCAAT box motif (Fig.3.2.A) or Sp1 motif (Fig. 3.2.B). A 
50-fold molar excess of unlabelled oligonucleotides efficiently competed for binding of 
nuclear factors. Furthermore, supershift assays confirmed that Sp1 and NF-Y did bind 
specifically to the Sp1 and CCAAT box motifs respectively. ChIP assays demonstrate 
that Sp1 and NF-Y bind the TBX2 proximal promoter in WI-38 human lung fibroblasts 
suggesting that they may be required for constitutive expression of TBX2 in these cells 
(Fig. 3.2.D). 
 
3.2.3. Sp1 binds the proximal TBX2 promoter regardless of the status of  
          the CCAAT box 
 
To investigate whether a physical interaction between Sp1 and NF-Y influences the 
binding of Sp1 to its cognate site, a DNA affinity immunoblot assay (DAI) was performed. 
Considering that the context of DNA may affect binding, two biotinylated probes of 170 
bp which contained the wild-type Sp1 and either the wild-type or mutant CCAAT box 
motif were generated by PCR and used in this assay. The results showed that a similar 
amount of Sp1 bound to both probes suggesting that the integrity of the CCAAT box 
motif did not affect its binding (Fig. 3.2.E). This is further illustrated by the observation 
that in the same experiment only unlabeled probes containing WT Sp1 motifs, 
regardless of the CCAAT box status, competed well for binding. To further explore the 
mechanism by which Sp1 transcriptionally regulates the TBX2 gene, co-transfection 
experiments were carried out with a Sp1 expression vector and either a wild type- or 
CCAAT box mutated TBX2 proximal promoter (-216/+32) luciferase construct. It is 
interesting to note that in these experiments the over-expression of Sp1 did not 
significantly activate the wild-type promoter, but led to a 2.6-fold activation of the CCAAT 
box mutant promoter (Fig. 3.2.F). 
 
3.2.4. A potential role for a DPE motif in the proximal promoter of the TBX2  
          gene 
 
To identify potential core promoter elements the proximal TBX2 promoter was screened 
for putative transcription factor binding sites (shown in Fig. 3.3.A) which were individually 











activity (Fig. 3.3.B). Interestingly a downstream core promoter element (DPE)-like motif 
(AGTCGCG) was found to be located from +26 to +32 and a 12bp deletion construct 
(from +20 to +32) exhibited a ~25% reduction in luciferase activity compared to the WT-
TBX2 proximal promoter. This DPE-like motif may thus also play a role in basal TBX2 
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Fig. 3.1. The proximal promoter of the human TBX2 gene (-216/+32) is sufficient for 
maintaining the majority of basal activity. (A) Schematic illustration showing the 
restriction enzymes used to generate a series of luciferase reporter constructs 
containing truncated 5’-flanking regulatory regions of the human TBX2 gene. (B) 
Sequence alignment showing homology between the human (top) and mouse (low) Tbx2 
proximal gene promoter. The asterisks denote nucleotides that deviate between human 
and mouse. Putative cis-regulatory elements are boxed. Nucleotides are numbered 
relative to the transcription initiation site (+1). Sequence database are from 
http://www.ensemble.org. (C) Plasmids containing sequentially deleted fragments of the 
human TBX2 promoter-luciferase reporter (500 ng) were transiently transfected into the 
HT1080 cell line together with the plasmid pRL-TK (50 ng) containing the Renilla 
luciferase reporter gene. (D) 500 ng proximal promoter construct (-216/+32) and its 
mutants (Sp1MUT, CCAAT-box MUT, and Sp1+CCAAT MUT) were co-transfected with 
50 ng internal control pRL-TK into HT1080 cells respectively. Firefly luciferase activity 
was normalized to renilla luciferase activity. Activation fold values were calculated by 
setting wild type promoter activity to 1.  Values represented are mean(±) from three 
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Fig. 3.2. Sp1 and NF-Y bind the TBX2 promoter at Sp1 and CCAAT motifs respectively. 
(A, B) For EMSA, 32P-labeled double-stranded oligonucleotide probes containing either 
the Sp1 site or the CCAAT-box respectively were incubated with 5 μg of nuclear extracts 
from WI-38 cells. Competition analysis was carried out in the presence of a 50-fold molar 
excess of unlabeled wild-type or mutated probes. For supershift assay, antibodies for 
Sp1 or NF-YA were included in the reactions and the arrow indicates a supershift band. 
(C) Schematic illustration of the region of the TBX2 proximal promoter with the positions 
of the putative Sp1 and CCAAT-box motifs are represented as black boxes. (D) ChIP 
assays were performed with antibodies for Sp1 or NF-YA, and PCR was performed with 
the primer pairs indicated by arrows in (C) above. Inputs and no antibody are shown as 
positive and negative controls respectively. (E) For DAI analysis, biotinylated wild-type 
(containing Sp1 site and CCAAT-box) or mutant CCAAT-box DNA fragments were 
generated by PCR using indicated primer pairs and immobilized on streptavidin beads. 
After incubation with nuclear extracts, the DNA-bound Sp1 complexes were analyzed by 
gel electrophoresis followed by immunoblotting using an antibody to Sp1. Competition 
assay were performed in the presence of a 5-fold excess of unlabeled wild-type or 
mutant CCAAT-box DNA fragments. (F)  500 ng wild-type construct (-216/+32) or its 
mutants (Sp1MUT, and Sp1+CCAAT MUT) was cotransfected with or without 200 ng 
Sp1 expression vector into HT1080 cells. Firefly luciferase activity was normalized to 
renilla luciferase activity. Fold activation values were calculated by setting without Sp1 
expression vector promoter activity to 1. Mean valu s (±) represent from three 
independent experiments. (G) Co-transfection with Sp1 expression vector, 

































Figure 3.3  See overfeaf for legend 
 
                              
                        -20       -10        +1       +10       +20       +30            
Wild type:       5’  ACATGTGAGATAGTCACAGTTTTCCAGAGATCACAACAAGATCTAACCAGTCGCGCG  3’ 
 
MUT1                                              AgttC 
 
MUT2                                         CctcGA 
 
MUT3 (EtsA MUT)                           TTaaA 
 
MUT4                               CAaAaTTT 
 
MUT5 (GATA MUT)               ATttTtA     
 
MUT6 (E-box MUT)       ATtTtcGA      
 


















Fig. 3.3. Functional characterization of the putative DPE in the human TBX2 gene. (A)  
Nucleotide sequence of the region in which site-specific mutations were introduced in 
the TBX2 gene. The mutated nucleotides are indicated with lowercase letters, and the 
putative DPE is underlined. (B) 500 ng of the proximal TBX2 promoter (-216/+32) 
construct, its mutant or the deletion proximal promoter (-216/+19) construct was co-
transfected with 50 ng pRL-TK into HT1080 cells. Firefly luciferase activity was 
normalized to renilla luciferase activity. The basal activity of the -216/+32 construct was 









































This study reports on the successful cloning of the 5’-regulatory region of the human 
TBX2 gene from the WI-38 fibroblasts and the identification of cis-elements essential for 
its basal transcriptional activity. While no consensus TATA box was found, a Sp1 and an 
inverted CCAAT box element were identified that are essential for basal promoter 
activity. This is in keeping with previous studies that have demonstrated that proximal 
Sp1 and CCAAT box elements play a critical role in activating transcriptional initiation in 
TATA-less promoters (Samson and Wong, 2002; Mantovani, 1999). Furthermore, 
inverted CCAAT boxes are more frequently found in TATA-less promoters (Mantovani, 
1998). Our data showed that individual mutations of the Sp1 and CCAAT box motifs 
caused 6.7-fold and 4.6-fold decrease in transcriptional activity of the TBX2 proximal 
promoter respectively. We further demonstrated that Sp1 and NF-Y specifically bind to 
putative Sp1 and CCAAT box elements respectively and are constitutively bound to the 
proximal TBX2 promoter in vivo.    
The physical interaction between Sp1 and NF-Y was previously reported to result in 
transcriptional activation of several genes (Liang et al., 2001; Yamada et al., 2000). The 
juxtaposition of Sp1 and CCAAT box elements in the TBX2 promoter therefore led us to 
further explore the possibility that Sp1 co-operates with NF-Y in regulating transcription 
of the TBX2 gene. DAI analysis showed no significant difference in the binding of the 
Sp1 protein to a wild type TBX2 promoter fragment and a TBX2 promoter fragment with 
a mutation within the CCAAT box. Although we cannot rule out the possibility that a 
potential physical interaction may exist between Sp1 and NF-Y, the findings of our 
functional analysis imply that physical and functional interaction between Sp1 and NF-Y 
may not be required to maintain optimum basal activity of the TBX2 promoter.  
Both Sp1 and NF-Y have been shown to associate with TATA box binding protein (TBP) 
and several TB-associated factors (TAFS) (Bellorini et al., 1997; Frontini et al., 2002; 
Emili et al., 1994; Chiang et al., 1995; Tanese et al., 1996) which are believed to be 
critical in transcription initiation. To our surprise, overexpression of Sp1 failed to increase 
wild type TBX2 promoter activity, but led to an increased activity (2-3-fold) of the TBX2 
promoter carrying a mutation in the CCAAT box motif. Taken together this suggests that 
while NF-Y and Sp1 have overlapping roles in transcription initiation they also have 











appears to be important for maintaining optimum basal activity of the TBX2 promoter. 
This may explain why mutation of both Sp1 and CCAAT box motifs resulted in a stronger 
(13.5-fold) decrease in luciferase activity compared with the combined effect seen when 
they were individually mutated (11.3-fold). This difference was regarded as potentially 
important because it was observed in every experiment performed. Our findings thus 
reveal possible new insights into the regulation of transcription by Sp1 which may 
depend on the context of the promoter.    
Core promoters comprise DNA sequence motifs within -40 to +40 nt relative to the 
transcriptional start site. A key role of the core promoter is to direct the initiation of 
transcription and the TATA box, the Initiator (Inr) and DPE are well described core 
promoter elements. The DPE consensus sequence is A/G-G-A/T-C/T-G/A/C and is 
generally located at around +28 to +34. The DPE is most commonly found in TATA box-
less promoters (Smale and Kadonaga, 2003). Here, we show that a potential DPE-like 
motif is located between +26 and +32 relative to the transcriptional start-site in the 
proximal TBX2 promoter and deletion of this motif caused a significant decrease (25%) 
in promoter activity. Although previous studies have shown that the DPE together with 
the Inr participates in regulating transcription initiation (Burke and Kadonaga, 2006), we 
did not find any other potential motif which significantly altered basal promoter activity 
around the transcription start site (from -30 to + 10). Although the DPE has been shown 
to be present in human genes, most work reporting on its involvement in transcriptional 
regulation has focused on Drosophila genes (Smale and Kadonaga, 2003). Whether the 
DPE identified in the TBX2 promoter is functional is worthy of further investigation and 
future work will be needed to determine whether general transcription factors are able to 
bind to it.  
 
In mouse melanocytes and melanoma cells, the transcription factors Mitf and USF-1 
have been shown to activate the mouse Tbx2 promoter through binding an E-box 
element in the proximal promoter (Carreira et al., 2000). Our current data suggest that 
this E-box element is not essential for basal activity of the TBX2 proximal promoter. Gel 
shift analysis however showed that this E-box element was bound by nuclear factor(s) 
(see appendix 2). To date, a battery of transcription factors have been shown to 
recognize the E-box element. The complex mechanisms involved in the regulation of 











remodeling (Bouchard et al., 2007; Baudino and Cleveland, 2001; Boyd et al., 1998). 
Taken together, this implicates a potential role for the E-box element in regulating tissue 
specific and inducible expression of the Tbx2 gene.  
 
Having cloned the human TBX2 5’-regulatory region and having identified key cis-acting 
elements required for its basal transcription we next focused on the regulated expression 




























3.4. Materials and methods 
 
3.4.1. Cloning of the 5’-flanking region of the human TBX2 gene 
 
We have previously demonstrated high levels of TBX2 expression in normal human WI-
38 lung fibroblasts (Teng et al., 2007). Based on the human genome sequence database 
from http://www.ensemble.org, we designed primers (Forward:  5’-
GTAGGGATAACGGTCGCAGA-3’; Reverse:  5’-GCGCGACTGGTTAGATCTTG-3’) to 
enable us to amplify the 5’-regulatory region of the TBX2 gene. Human genomic DNA 
isolated from WI-38 cells was used to clone the 5’-flanking region of the TBX2 gene by 
polymerase chain reaction (PCR) and the PCR product was cloned into the SmaI site of 
the pGEM-3Z vector.  The orientations and the sequences of the inserts were confirmed 
by restriction enzyme digestion and sequencing. 
 
3.4. 2. Plasmid constructs 
 
The human TBX2 promoter luciferase reporters were generated by inserting the SacI(-
1606)-HindIII(+32), MluI (-1081)-HindIII (+32), KpnI (-955)-HindIII (+32), SmaI (-365)-
HindIII (+32), SspI (-216)-HindIII (+32), and SspI (-216)-BgIII (+19) fragments of the 
TBX2 gene (Fig. 1A) into the appropriately cleaved luciferase reporter vector pGL3-basic 
(Promega, USA). The pRL-TK vector (Promega, USA) was used as an internal control 
reporter to test for transfection efficiency. The pCMV-Sp1 expression vector was 
obtained from Dr. Tjian (Department of Molecular & Cell biology, University of California, 
Berkeley) through Addgene. 
 
Site-directed mutagenesis was carried out with the QuickChange kit from Stratagene 
following the manufacturer’s instructions. All mutant constructs were generated using the 
proximal promoter construct (-216/+32) as a template. The oligonucleotides used for 
mutagenesis (only sense-strand presented and mutations indicated with lowercase 
letters) are the following:  
Mut1: 5’-AGTCACAGTTTTCCAGAGAgttCGACAAGATCTAACCAGTCG C-3’  















Mut7: 5’-CAGGACATtTtcGAaAtTtAaAaTTTTCCAGAGATCACGACAAGATCTAAC-3’                    
The mutated nucleotide sequences of all mutant constructs were verified by sequencing. 
 
3.4.3. Cell culture  
WI-38 human embryonic lung fibroblasts (ATCC CCL-75) and HT1080 human fibrosarcoma 
(ATCC CCL-120) cell lines were maintained in Dulbecco’s-modified Eagle medium 
supplemented with 10% fetal calf serum, 100 U/ml penicillin and 100 µg/ml streptomycin. Cells 
were maintained at 37C in an atmosphere of 5% CO2.  
 
3.4.4. Transfections and reporter assays 
 
Cells were plated at 1.5 x 105 cells/ml in six-well plates 1 day before transfection. Non-
liposomal mediated gene transfer was performed using FuGENE®6 (Roche Applied 
Science) according to manufacturer’s instructions with 1 g of DNA consisting of the 
reporter construct, and/or the Sp1 expression vector and the internal control vector. 
Thirty hours after transfection, cells were analyzed for luciferase activity using the Dual-
Luciferase Reporter Assay (Promega, USA) following manufacturer’s instructions and 
quantified with a Luminoskan Ascent Luminometer (Thermo LabSystems, USA).  
 
3.4.5. Electrophoretic mobility shift (EMSA) and DNA affinity   
          immunoblotting (DAI) Assays 
 
Nuclear extracts were prepared from WI-38 cells as previously described (Lee and 
Green, 1990). For EMSA, double-stranded oligonucleotides containing a Sp1 site or 
CCAAT-box were end-labeled with [γ-32P]ATP using T4 polynuceotide kinase. The 
labeled probes were incubated with 5 μg nuclear extracts in binding buffer [20 mM Tris-
HCl (pH 7.6), 50 mM NaCl, 1 mM MgCl2, 0.2 mM EDTA, 0.5 mM DTT, 5% glycerol and 2 
μg poly(dI-dC) ] in a final volume of 20 μl . For supershift analysis, antibodies for Sp1 or 
NF-YA (Santa Cruz Biotechnology) were preincubated with nuclear extracts in binding 
buffer before the addition of probes. The reactions were resolved on 5% native 











are as follows (only sense-strand presented and mutations indicated with lowercase 
letters): 
Sp1 Wild type: 5’-CTGTCAAAACCCCGCCCCCGGAGACCC-3’  
Sp1 Mut: 5’-CTGAGCTGTCAAAACCCaGaaCCCGGAGACCCACAATTG-3’ 
CCAAT-box Wild type:  5’-GAGACCCACAATTGGTCCAAAAAGCGTAA-3’ 
CCAAT-box Mut: 5’-CCGGAGACCCACAATTatTCCAAAAAGCGTAAAATCAGCAATC-3’ 
 For DAI assays, biotinylated DNA probes were generated by PCR using primer pairs of 
5’-biotin modification (Forward: 5’-TGGCCTGAGCTGTCAAAAC-3’; Reverse: 5’- 
GCGCGACTGGTTAGATCTTG-3’) and immobilized on Dynabeads Streptavidin (Dynal 
Invitrogen) according to the manufacturer’s instructions. For each reaction, 40 μg 
nuclear extract was incubated with 1 μg DNA probe in binding buffer (same as for EMSA) 
in final volume of 400 μl. The beads were extensively washed with binding buffer and 
then boiled in 25 μl of 2x loading buffer before SDS-polyacrylamide gel electrophoresis 
followed by immunoblotting. 
 
3.4.6. Chromatin immunoprecipitation assay (ChIP) 
 
ChIP assays were carried out as previously described (Prince et al., 2004). Briefly, WI-
38 cells expressing endogenous TBX2 were fixed in 1% formaldehyde. The chromatin 
was extracted in lysis buffer (1% SDS, 10 mM EDTA, 50 mM Tris-HCL, pH 8.1) with a 
proteinase inhibitor, sonicated to an average length of about 500 bp, and DNA-
containing fractions were incubated overnight with antibodies to Sp1 or NF-YA and 
collected on protein G beads.  Cross-linked products were reversed by heating at 65C 
for 4 hours, and the immunoprecipitated DNA was purified by proteinase K treatment. 
The precipitated DNA was analyzed by PCR using TBX2 specific primer pairs (Forward: 


















CHAPTER  4 
 
PHOSPHORYLATION OF HISTONE H3 BY BOTH PKC AND MAPK 
SIGNALLING PLAYS A CRITICAL ROLE IN ACTIVATING THE EXPRESSION 
OF THE HUMAN TBX2 GENE 
 
 
4.1. Introduction  
 
The nucleosome is the basic building unit of chromatin and consists of a protein core of 
a histone octamer (H2A, H2B, H3 and H4) with 146 base pairs of DNA wound around it. 
N-terminal tails of histones protrude outside of the nucleosome and are thus readily 
subject to a variety of covalent modifications such as acetylation, phosphorylation, 
methylation, ubiquitination and ADP-ribosylation. These modifications have been 
proposed to cause an alteration of chromatin configuration and/or form a recognition 
motif allowing access of relevant proteins of transcription to regulate gene expression 
(Berger, 2002; Jenuwein and Allis, 2001). For example, phosphorylation of histone H3 
has been associated with transcriptional activation of c-jun and c-fos immediate-early (IE) 
response genes in response to growth factors and phorbol esters (Mahadevan et al., 
1991). The list of genes identified that are associated with stimulus-induced 
phosphorylation of H3 is growing (Clayton and Mahadevan, 2003).  
 
Protein Kinase C (PKC) represents an important multigene family of serine/threonine 
kinases that can be activated by various extracellular and intracellular signals and have 
been involved in broad and diverse functions in many physiological and pathological 
processes (Newton, 1997; Griner and Kazanietz, 2007). The PKC family comprises at 
least 12 isoforms that are divided into three subfamilies: conventional or classical PKCs 
(cPKCs; α, β 1/2 and γ), novel PKCs (nPKCs; δ, ε, η, and θ), and atypical PKCs (aPKCs; 
ζ and λ/ι). PKC is a major intracellular target of 12-O-tetradecanoylphorbol-13-acetate 
(TPA) and it is well established that in response to TPA, PKCs can activate the 
Ras/Raf/MEK/ERK MAPK pathway. There is also accumulating evidence suggesting 
that TPA can activate p38 and JNK in a cell-type dependent manner (Lόpez-Bergami et 












Given the important role that Tbx2 plays in embryonic development and carcinogenesis 
there is a need to understand the mechanism(s) regulating Tbx2 gene expression. 
However, while several signalling pathways, including FGF, BMP and Shh have been 
associated with the regulation of Tbx2 expression the details of this regulation remain 
unknown (Rowley et al., 2004; Suzuki et al., 2004; Nissim et al., 2007). One of the aims 
of the present study was therefore to investigate the regulation of Tbx2 gene expression 
by signalling pathways and the results demonstrate that TPA induces TBX2 gene 
expression in normal human lung fibroblasts in a PKC-dependent and MAKP-
independent manner. However, we also show that p38 and Erk1/2 signalling are 
involved in regulating TBX2 gene expression in transformed human fibroblasts. We 
further reveal that TPA-induced phosphorylation of histone H3 plays a critical role in 
regulating TBX2 gene expression. Moreover, we provide evidence to link PKC to MSK1, 




























4.2. Results  
 
4.2.1. Induction of TBX2 gene expression by TPA in human fibroblasts 
 
We have previously shown that TBX2 is expressed at high levels in the normal human 
lung fibroblast cell line, WI-38, but that it is expressed at very low levels in WI-38 
transformed cell lines, CT and SVWI-38 (Teng et al., 2007). To identify signalling 
pathways that regulate TBX2 expression we first examined the effect of TPA treatment 
of WI-38 cells on Tbx2 by western blot analysis. Our results show that TPA significantly 
induces Tbx2 expression in a time-dependent manner (Figure 4.1A). The up-regulation 
of Tbx2 can be observed from 4 hr to 24 hr, and maximally at 8 hr. Interestingly, TBX2 
expression was strongly induced in the CT and SVWI-38 cells, which express very low 
levels of Tbx2, when they were treated with TPA for 8 hrs (Figure 4.1B). 
 
In order to determine whether the above induction of Tbx2 expression by TPA is due to 
an increase in transcription, cells were treated with or without TPA for a period spanning 
1 hr to 24hr and Tbx2 mRNA levels assessed by real-time PCR. Our results show that 
Tbx2 mRNA levels were up-regulated from 2hr with levels peaking at 8hr (Figure 4.1C) 
in WI-38 cells. The same increase in Tbx2 mRNA levels was observed when SVWI-38 
and CT-1 cells were treated with TPA for 8 hr (Figure 4.1D). In response to TPA, Tbx2 
mRNA levels therefore closely correlate with levels of Tbx2 protein which suggest that 
TPA induces Tbx2 expression at a transcriptional level. 
 
4.2.2. Induction of TBX2 gene expression by TPA in WI-38 cells is PKC-           
dependent  
 
To investigate the pathway(s) by which TPA up-regulates TBX2 gene expression in WI-
38 cells, we first examined the phosphorylation of MAPKs by western blot analyses. 
Figure 4.2A shows that 1hr to 8 hr of TPA treatment leads to an increase in Erk1/2 
phosphorylation, a marginal increase in phosphorylated p38 at only 4 hr treatment and 
undetectable changes in JNK phosphorylation. 
 
To assess the involvement of the above signalling molecules in TPA-induced expression 











(PD98059), p38 (SB203580), and JNK (SP600125) before TPA treatment and then 
analysed TBX2 expression by western blotting. As shown in Figure 4.2B, while both 
PD98059 and SB203580 have no effect on the induction of Tbx2 expression at 8 hr of 
TPA treatment, SP600125 block TPA-induced Tbx2 expression at this time point. Similar 
results were also obtained at 4hr of TPA treatment (see appendix 3). It is interesting to 
note that GF109203 repress both TPA-induced and basal TBX2 expression. This finding 
suggests that constitutive activity of PKC may be essential for TBX2 expression in WI-38 
cells.  
 
To determine the blocking efficiency and specificity of the above inhibitors, their effect on 
phosphorylation of MAPKs were examined. Our results (Figure 4.2C, D) show that 
PD98059 and SB20358 can sufficiently reduce phosphorylation of Erk1/2 and p38 
respectively. Surprisingly, although TPA was not shown to enhance JNK 
phosphorylation, TPA-mediated TBX2 expression was repressed by SP600125 
 
4.2.3. Regulation of Tbx2 gene expression by MAPK signalling is cell type- 
           dependent  
 
To explore this possibility with regard t  TPA-mediated Tbx2 expression the above 
experiment was performed in CT-1 and SVWI-38 cells. The results shown in Figure 4.3A 
and 4.3B reveal that PD98059 reduced the effect of TPA on TBX2 expression in both 
SVWI-38, and CT-1 cells respectively and this corresponded with a block in Erk 
phosphorylation (Figure 4.3C and 3D). Interestingly, a similar effect is seen when CT-1, 
but not SVWI-38, cells were pretreated with SB203580.  
 
4.2.4. TPA and AP1 does not activate a Tbx2 gene reporter construct  
 
It is well-documented that TPA induces the expression of numerous genes through up-
regulation of AP1 and we therefore examined the expression of c-Jun and JunB in WI-38, 
SVWI-38 and CT-1 cells treated with or without TPA by western blot analyses. Results 
show that TPA increases both c-Jun and JunB protein levels in a time-dependent 
manner which correlates with an up-regulation of TBX2 in all three cell lines tested 











To determine whether AP-1 can indeed regulate the TBX2 promoter we searched the 
3000bp 5’-flanking regulatory sequence of the human TBX2 gene which was obtained 
from the human genome sequence database (http://www.ensemble.org), for potential 
cis-acting elements using the TFSEARCH program 
(www.cbrc.jp/research/db/TFSEARCH.html). A putative AP-1 site was found at -1069 
relative to the transcriptional start site (data not shown) and we thus performed 
luciferase assays using a reporter construct driven by a 1638bp sequence of the TBX2 
gene containing this putative site (see Chapter 3). TPA failed to stimulate transcriptional 
activity of the human TBX2 promoter in SVWI-38 and HT1080 cells (Figure 4.4C), and 
over-expression of c-Jun or JunB did not significantly increase Tbx2 promoter activity in 
HT1080 cells (Figure 4.4D). These findings led us to hypothesize that either distal 
elements not present in the 1638bp Tbx2 regulatory fragment may be mediating the 
effects of TPA or that a chromatin remodeling mechanism may be involved in 
transcriptional regulation of TBX2 gene expression by TPA. 
4.2.5. Phosphorylation of histone H3-Ser10 is required for binding of Sp1  
            to the TBX2 gene in WI-38 cells  
 
Several lines of evidence suggest that translational modification of histone H3 leads to 
the activation of genes in a Sp1 site dependent manner (Han et al., 2001; Tone et al., 
2007; Takakura et al 2001; Schuettengruber et al., 2003). Furthermore, TPA-inducible 
histone H3 phosphorylation has been correlated with transcriptional activation of several 
immediate-early (IE) genes such as c-Fos and c-Jun (Clayton and Mahadevan 2003). 
We have previously demonstrated that the basal transcription of the human TBX2 gene 
is dependent on a Sp1 site in its proximal promoter (see chapter 3). This led us to ask 
the question as to whether TPA induces TBX2 expression through phosphorylating 
histone H3, hence recruiting Sp1 to the Sp1 site identified above. Western blot analyses 
were therefore performed to examine TPA-inducible phosphorylation of histone H3 in 
WI-38 cells. Our results show that TPA treatment results in increased levels of 
phosphorylated histone H3-Ser10 from 1hr and is sustained up to 8hrs of treatment 
(Figure 4.5A). 
 
We next examined whether TPA induces histone H3-Ser10 phosphorylation at the TBX2 
promoter using ChiP assays. Primers spanning the proximal promoter of TBX2 (Figure 











quantitative analysis was performed by real-time PCR. Compared to untreated cells, an 
approximately two fold increase in histone H3-Ser10 phosphorylation was obtained at 
the TBX2 promoter in WI-38 cells treated with TPA for 8hr (Figure 4.5C, D). To explore 
the possibility that TPA enhances Sp1 binding to the TBX2 promoter, the same primers 
shown in Figure 4.5B were used to amplify DNA fragments immunoprecipitated with an 
antibody specific to Sp1. A significant increase of Sp1 was observed at the TBX2 
promoter in WI-38 cells treated with TPA (Figure 4.5C, D). 
 
4.2.6. PKC-dependent phosphorylation of histone H3-Ser10 correlated with  
           activation of MSK1 
 
Whereas several kinases, including MSK1/2 (Thomson et al. 1999; Soloaga et al., 2003), 
ribosomal S6 kinase 2 (RSK2) (Sassone-Corsi et al., 1999), PKA (Salvador et al., 2001), 
PKC (Huang et al., 2004), and IкB kinase-α (IKK-α) (Park et al., 2006) have been 
proposed to phosphorylate histone H3 in response to various stimuli, current evidence 
suggests that MSK1 and 2 are the primary kinases involved (Clayton and Mahadevan 
2003). We therefore investigated whether MSK1 was activated in WI-38 cells treated 
with TPA by reprobing the western blot shown in Figure 4.5A with an antibody to 
phosphorylated MSK1. An increase in MSK1 phosphorylation was evident from 1hr and 
persisted over a period of 24 hr of TPA treatment (Figure 4.5A). To identify the signalling 
pathway implicated in this phosphorylation, the effect of PKC (GF109203X), Erk 
(PD98059), p38 (SB20358) and JNK (SP600125) inhibitors were included in 
experiments in which WI-38 (Figure 4.6A), SVWI-38 and CT-1 cells (Figure 4.6B) were 
treated with TPA for 8hr. The results reveal that whereas both TPA-mediated 
phosphorylation of MSK1 and histone H3-Ser10 were abolished by GF109203X, no 
significant effect was observed for the PD98059 and SB20358 inhibitors in WI38 cell 
(Figure 4.6A). These findings suggest a functional link between PKC and MSK1 
activation during TPA-mediated phosphorylation of histone H3-Ser10.  
 
Interestingly, while both the PD98059 and SB20358 inhibitors led to a decrease in MSK1 
phosphorylation in CT-1 cells treated for 8hr with TPA, we failed to detect alterations in 
global phosphorylation of histone H3-Ser10 under the same conditions (Figure 4.5B). 











global phosphorylation of histone H3-Ser10 in SVWI-38 cells treated with TPA for 8hr 
(Figure 4.6B).  
 
4.2.7. SP600125 reduces Phosphorylation of histone H3-Ser10 in a MSK1- 
           dependent manner 
 
Results shown in Figures 4.2A, C, D and 4.3C, D indicated that TPA did not significantly 
activate JNK in the three fibroblast cell lines used in this study. However, SP600125 was 
shown to block TPA-induced expression of TBX2 in all three these cell lines and this 
paralleled with the reduction of histone H3-Ser10 phosphorylation as well as MSK1 
phosphorylation seen (Figure 4.6.). Interestingly, SP600125 has recently been identified 
to act as an inhibitor of histone H3-Ser10 phosphorylation through an unknown 
mechanism (Huang et al., 2007). Our findings suggest that SP600125 may repress 
phosphorylation of histone H3-Ser10 through blocking MSK1 activation. Furthermore, we 
also provide evidence to support a critical role of histon  H3-Ser10 phosphorylation in 
activating the expression of the human TBX2 gene. 
 
4.2.8. Effect of TPA on Sp1 expression and DNA binding activity  
 
We have clearly shown here that TPA-induced phosphorylation of histone H3-Ser10 was 
associated with recruitment of Sp1 to a Sp1 site in the human TBX2 gene. However, 
several lines of evidence have also shown that TPA-mediated expression of certain 
genes is associated with increased levels of total and/or phosphorylated Sp1 (Samson 
and Wong, 2002). To test whether the TPA-mediated increase in TBX2 gene expression 
is also due to the latter mechanism involving increased levels of Sp1 we next examined 
the expression pattern of Sp1 in WI-38 cells treated with or without TPA. Western 
blotting reveals that there is no significant change in total (Figure 4.7A) and nuclear 
(Figure 7B) Sp1 protein levels at time points tested and thus excluded this possibility. In 
addition, Sp1 protein levels were not significantly influenced in the presence of the PKC, 
JNK, p38 and Erk inhibitors (4.7 C).  
To further explore whether there was an effect of TPA on nuclear factors binding to the 
Sp1 site in the proximal TBX2 promoter, DAI assays were carried out. Our results show 











not enhance Sp1 binding to this site (Figure 4.7D left). However, experiments in which 
unlabelled probe was included to compete with labeled probe indicated that nuclear 
factors from TPA-treated cells bound to the Sp1 site more stably compared to those from 













































Figure 4.1.  Induction of TBX2 expression by TPA in human fibroblasts. WI-38 (A and B) 
and SVWI-38 and CT-1 (C and D) cells were treated with either vehicle (control) or TPA 
(100 nM) for the indicated times. Whole cell lysates and total RNA were harvested and 
subjected to western blot (A and C) or real-time PCR (B and D) analyses, respectively.    





















Figure 4.2. TPA stimulates TBX2 gene expression in a PKC-dependent manner in WI-
38 cells.  (A)  WI-38 cells were treated with either vehicle (control) or TPA (100 nM) for 
the indicated times. Whole cell lysates were harvested and subjected to western blotting 
to detect phosphorylated JNK, p38, and Erk1/2. Total Erk2 or total p38 were detected as 
loading controls. (B and C)  WI-38 cells were pretreated with vehicle or 20 μM 
GF109203X, 25 μM PD 98095, 20 mM SP600125 and 10 μM SB203580 for 1 hr and 
then treated with TPA (100 nM) for 8 hr. Western blots were carried out to detect levels 
of Tbx2 (B) and phosphorylated JNK, p38 and Erk1/2 (C). Total Erk2 or total p38 or α-
tubulin was detected as loading control. (D) WI-38 cells were treated with vehicle or TPA 

















Figure 4.3.  Erk and/or p38 signalling are involved in the regulation of TBX2 expression 
by TPA in SVWI-38 and CT-1 cells. SVWI-38 (A and C) and CT-1 (B and D) cells were 
pretreated with vehicle or 20 μM GF109203X, 25 μM PD 98095, 20Μm SP600125 or 10 
μM SB203580 for 1 hr and then treated with TPA (100 nM) for 8 hr.  Western blots were 
carried out to detect Tbx2 (A and B) and phosphorylated JNK, p38 and Erk1/2 (C and D). 
















Figure 4.4.  TPA, c-Jun and JunB do not affect human TBX2 promoter activity. (A and B) 
TPA stimulated expression of c-Jun and JunB in human fibroblasts.  WI-38, SVWI-38 
and CT-1 cells were treated with either vehicle (control) or TPA (100 nM) for the 
indicated times. Whole cell lysates were harvested and subjected to western blot 
analysis with the indicated antibodies. (C) The TBX2 promoter-luciferase reporter (500 
ng) was co-transfected into SVWI-38 and CT-1 cells with the internal control pRL-TK (50 
ng) in the presence or absence of TPA (100 nM for 12 hr). Luciferase activity was 
measured 30 hr post-transfection and normalized to renilla luciferase activity. Activation 
fold values were calculated by setting untreated promoter activity to 1. Mean values (±) 
were calculated from three independent experiments. (D) The TBX2 promoter-luciferase 
reporter (500ng) was co-transfected into HT1080 cells either with the empty pCMV (200 
ng) vector or c-Jun or JunB (200 ng) expression vectors and luciferase activity 
determined as in (C) above.  Activation fold values were calculated by setting the effect 
of empty pCMV vector on TBX2 promoter activity to 1. Mean values (±) were calculated 















Figure 4.5. Induction of TBX2 expression by TPA in WI-38 cells is associated with 
recruitment of Sp1 to the TBX2 promoter and histone H3-Ser10 phosphorylation (A) TPA 
stimulated increase of global histone H3-Ser10 phosphorylation and activation of MSK1. 
WI-38 cells were treated with either vehicle (control) or TPA (100 nM) for the indicated 
times. Whole cell lysates were harvested and subjected to western blot analysis with the 
indicated antibodies. To enable the detection of phosphorylated MSK1, proteins were 
separated on 6% SDS-PAGE and where more than one band is present, the upper band 
represents the phosphorylated MSK1. (B) Schematic illustration of the region of TBX2 
proximal promoter showing the putative Sp1 site (boxed). Arrows represent primer pairs 
used for PCR. (C)  WI-38 cells were treated with either vehicle (control) or TPA (100 nM) 
for 8 hr and Chip assays were performed with antibodies against Sp1 or phospho-H3. 
Co-immunoprecipitated DNA was assayed by PCR with primer pairs indicated in (A) 
above. Inputs and no antibody are positive and negative controls respectively. (D) Co-
immunoprecipitated DNA was assayed by real-time PCR and was normalized to input. 



























Figure 4.6. TPA activates MSK1 which correlates with phosphorylation of histone H3-
Ser10 in a PKC-dependent manner. (A and B) WI-38, SVWI-38 and CT-1 cells were 
pretreated with vehicle or 20 μM GF109203X, 25 μM PD 98095, 20 Μm SP600125 or 10 
μM SB203580 for 1 hr and then treated with TPA (100 nM) for 8 hr. Western blots were 
carried out to detect phosphorylated histone H3-Ser10 and MSK1 and tubulin was 
included as a loading control. To enable the detection of phosphorylated MSK1, proteins 
were separated on 6% SDS-PAGE and where more than one band is present, the upper 




















Figure 4.7.  TPA has no effect on Sp1 expression but stabilizes its binding to the TBX2 
promoter. (A) WI-38 cells were treated with either vehicle (control) or TPA (100 nM) for 
the indicated times and cell lysates subjected to western blot analysis to detect Sp1.  
(B) As for (A) above but cells were pretreated with vehicle or 20 μM GF109203X, 25 μM 
PD 98095, 20 Μm SP600125 or 10 μM SB203580 for 1 hr prior to TPA treatment (8 hr).  
(C) As for (A) above but nuclei were prepared for WI-38 cells treated with either vehicle 
(control) or TPA (100 nM) for 8 hr.  (D) For DAI analysis, biotinylated DNA fragments 
were generated by PCR using indicated primer pairs (Figure 4.5B) and immobilized on 
streptavidin beads. After incubation with nuclear extracts (40 μg), the DNA-bound Sp1 
complexes were analyzed by gel electrophoresis followed by immunoblotting using an 
antibody for Sp1. Competition assays were performed in the presence of a 5-fold excess 


















Figure 8.  A schematic representation of proposed model. Phosphorylation of histone 
H3 leads to chromatin remodeling, hence recruitment of Sp1 to TBX2 promoter which 
results in the activation TBX2 gene transcription. In this process, TPA can activate the 
histone H3 kinase MSK1 through mainly PKC, but also through a PKC-dependent Erk 



















4.3. Discussion  
 
The mechanisms involved in the transcriptional regulation of the Tbx2 gene are still 
poorly understood. In view of the detrimental consequences resulting from altered levels 
of T-box proteins, as seen in both developmental disorders and in certain cancers, the 
need to identify such mechanisms is important.  Here we demonstrate for the first time 
that TPA treatment of normal and transformed human fibroblasts leads to a time-
dependent increase in Tbx2 mRNA and protein levels and we provide compelling 
evidence that this results from TPA regulating TBX2 transcription through a process 
involving phosphorylation of histone H3.  
 
It is well established that phosphorylation of histone H3 plays a critical role during 
transcriptional activation of IE genes in response to various stimuli. Phosphorylation of 
histone H3 has also been linked to transcriptional activation of several relative late 
response genes (Clayton and Mahadevan 2003; Ge et al., 2006). Here, we show that 
TPA increases both histone H3-Ser10 phosphorylation and Sp1 recruitment to a Sp1 site 
in the TBX2 proximal promoter which correlates with the induction of TBX2 expression. 
This is in keeping with our previously published data which identified this Sp1 site to be 
essential in maintaining basal activity of a human TBX2 promoter (see chapter 3). 
Moreover, blocking histone H3-Ser10 phosphorylation is associated with abolishing Tbx2 
induction. These findings suggest TPA activates transcription of TBX2 through 
phosphorylation of histone H3 and recruitment of Sp1 to the Sp1 site in the TBX2 
proximal promoter. 
 
Phosphorylation of H3 has also been shown to be necessary for chromosome 
condensation and chromosome segregation during mitosis (Gurley et al., 1978; Hendzel 
et al., 1997).To date, it is well-known that stimulus-mediated phosphorylation of histone 
H3 is transient and involves only a small fraction of histone H3 which is distinct from 
phosphorylation of the majority of H3 observed during mitosis (Clayton and Mahadevan 
2003; Johansen, 2006). Stimulus-mediated phosphorylation of histone H3 may therefore 
not be observed at a global level. Indeed, a reduced phosphorylation of global histone 
H3-Ser10 was found in some instances (Huang et al., 2004; Nowak and Corces 2000). 











phosphorylation in two transformed fibroblast cell lines and at a later time point in normal 
fibroblasts.  
 
MSK1 has been well characterized as a histone H3 kinase (Thomson et al. 1999; 
Soloaga et al., 2003). Mitogen- and stress- induced phosphorylation of histone H3 has 
also been demonstrated to be mediated by the Erk and/or p38 MAPK cascades in many 
different systems (Clayton and Mahadevan 2003). PKC has been proposed as a histone 
H3 kinase responsible for histone H3-Ser10 phosphorylation at the LDL receptor 
promoter in response to TPA in human hepatoma HepG2 cells (Huang et al., 2004). 
Here we show that TPA activates MSK1 which is associated with phosphorylation of 
histone H3 in a PKC-dependent and MAPK- independent manner in WI-38 cells. 
Although we can not rule out the possibility that PKC may also directly phosphorylate 
histone H3-Ser10, our findings clearly suggest that MSK1 is a potential downstream 
target of PKC and is linked to phosphorylation of histone H3. 
 
Although we did not detect activation of JNK by TPA in our system, it is intriguing to note 
that the JNK inhibitor, SP600125, resulted in an apparent repression of TBX2 expression 
which was associated with a reduction of global phosphorylation of histone H3. 
Consistent with our finding, SP600125 has been shown to reduce global histone H3-
Ser10 phosphorylation in a JNK MAPK independent manner in human hepatocellular 
HepG2 cells (Huang et al., 2006).  However, our results also indicated that SP600125 
inhibits MSK1 activity.  Since SP600125 has been shown to be capable of inhibiting a 
variety of kinases (Bain et al., 2003), it is possible that it can act as an inhibitor of MSK1 
and thus block phosphorylation of histone H3. This possibility is worthy of further 
investigation.  
 
Although other studies have suggested that TPA leads to an increase in Sp1 levels in 
several systems (Noe et al., 2001; D’Angelo et al., 1996; Pornttadavity et al., 2001), our 
data here did not show that TPA can significantly affect Sp1 protein level in all types of 
fibroblast tested. However, TPA was shown to significantly enhance stability of nuclear 
factor binding to Sp1 site in TBX2 promoter. TPA-induced phosphorylation of Sp1 has 
been shown to enhance Sp1 binding and transcription activity in human HepG2 cells 
(Zhang X-L et al., 2000), and phosphorylation and activation of Sp1 have also been 











and Ferro, 2005). Thus, whether Sp1 phosphorylation is also implicated in TPA-
mediated transcription activation of the TBX2 gene remains to be elucidated. 
Furthermore, we show that while TPA upregulates c-Jun/AP1 and JunB/AP1 expression 
which correlates well with up-regulation of Tbx2, TPA and c-Jun/JunB failed to activate a 
reporter gene driven by a 5’- regulatory region of the TBX2 gene. These findings provide 
indirect support for the possibility that TPA-mediated phosphorylation of histone H3-
Ser10 plays a critical role in transcriptional activation of the TBX2 gene.  
 
In conclusion, we show that in response to TPA, phosphorylation of histone H3 leads to 
the recruitment of Sp1 to a Sp1 site in the proximal TBX2 gene promoter which is critical 
for the induction of TBX2 gene expression. Furthermore, we demonstrate that this is 
mediated by PKC and involves MSK1. Interestingly, while MSK1 seems to be directly 
activated by PKC in normal fibroblasts, its activation appears to occur via Erk or p38 
signalling pathways in transformed fibroblasts (Figure 8). Our findings give insight into 


























 4.4. Materials and methods 
 
4.4.1. Cell culture and reagents 
WI-38 (ATCC CCL-75) normal human embryonic lung fibroblasts, their in vitro 
transformed counterparts WI-38 CT-1 (referred to as CT-1; Namba et al., 1980) and 
SVWI-38 cell lines were maintained in Dulbecco’s-modified Eagle medium (DMEM) 
supplemented with 10% fetal calf serum (FCS), 100 U/ml penicillin and 100 µg/ml 
streptomycin. Cells were maintained at 37C in an atmosphere of 5% CO2. For TPA 
treatment, 100 nM TPA was used (Sigma). The PKC inhibitor GF109203 (20 μM), MEK-
1 inhibitor PD98095 (25 μM), p38 inhibitor SB203580 (10 μM) and JNK inhibitor 
SP600125 (20 μM) (Calbiochem) were added 1 hr prior to treatment with TPA. 
 
4.4.2. Plasmids, Transfections and reporter assays 
 
The human TBX2 promoter luciferase reporter construct was generated by inserting the 
SacI(-1606)-Hind III(+32) fragment of the human TBX2 gene into the appropriately 
cleaved luciferase reporter vector pGL3-basic (Promega, USA). The pRL-TK vector 
(Promega, USA) was used as an internal control reporter to test for transfection 
efficiency. The pCMV-c-Jun and pCMV-JunB expression vectors were kindly provided by 
Dr Michael Birrer (National Institutes of Health, USA). Cells were plated at 1.5 x 105 
cells/ml in six-well plates 1 day before transfection. Non-liposomal mediated gene 
transfer was performed using FuGENE®6 (Roche Applied Science) according to 
manufacturer’s instructions using 1 g of DNA consisting of the reporter construct, 
expression vectors and the internal control vector. Thirty hours after transfection, cells 
were analyzed for luciferase activity using the Dual-Luciferase Reporter Assay 
(Promega, USA) following manufacturer’s instructions and quantified with a Luminoskan 
Ascent Luminometer (Thermo LabSystems, USA).  
 
4.4.3. Western blotting 
 
Western blot assays were carried as described previously (Teng et al., 2007). Proteins 
were resolved on 8-12% SDS-polyacrylamide gels, as required and transferred to 











appropriate primary antibodies and detected using peroxidase-conjugated anti-mouse or 
anti-rabbit antibodies (1:5000) and visualised by ECL (Pierce, USA). The primary 
antibodies used were: mouse monoclonal anti-Tbx2 62-2 antibody (1:2000), rabbit 
polyclonal anti-phospho-H3 (1:2000, Upstate Biotechnology), anti-phospho-p38 
(1:1000), anti-p38 (1:5000), anti-phospho-MSK1 (1:1000), anti-phospho-Erk1/2 (1:1000), 
anti-phospho-JNK (1:1000) (Cell Signaling Technology Inc., Beverly, MA), rabbit 
polyclonal anti-c-Jun, JunB, Erk2, Sp1 (1:500) and mouse monoclonal alpha-tubulin 
(1:500) from Santa Cruz Biotechnology, CA, USA. 
 
4.4.4. Real time RT PCR 
 
Total RNA was extracted from cultured cells and quantitative RT PCR assays were 
carried out using the LightCycler as previously described (Teng et al., 2007). Primers used 
for RT-PCR were human TBX2:  (forward) 5’- ATGGGCATGGGTCACCTACT-3’; 
(reverse) 5’- GGTGTAGGGGTATTTTAAGA -3’; Glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH): forward 5’-GAAGGCTGGGGCTCATTT-3’; reverse 5’-
CAGGAGGCATTGCTGATGAT-3’ 3 PCR conditions were as follows: 95°C for 10 min; 
and 45 cycles of 95°C for 45 seconds (denaturation), 59°C for 20 seconds (annealing), 
and 72°C for 20 seconds (extension). The PCR products of TBX2 were cloned into the 
pGEM-T easy vector (Promega, USA.) and verified by sequencing. 
 
4.4.5. DNA affinity immunoblotting (DAI) 
 
Nuclear extracts were prepared from WI-38 cells as previously described (Lee and 
Green 1990).  For DAI assays, biotinylated DNA probes were generated by PCR using 
primer pairs that were synthesized and 5' end-labeled with biotin (Forward: 5’-
TGGCCTGAGCTGTCAAAAC-3’; Reverse: 5’- GCGCGACTGGTTAGATCTTG-3’), and 
immobilized on Dynabeads Streptavidin (Dynal Invitrogen) according to the 
manufacturer’s instructions. For each reaction, 40 μg nuclear extract was incubated with 
1μg DNA probes in binding buffer [20 mM Tris-HCl (pH 7.6), 50 mM NaCl, 1 mM MgCl2, 
0.2 mM EDTA, 0.5 mM DTT, 5% glycerol and 2 μg poly(dI-dC) ] in a final volume of 











of 2x loading buffer before SDS-polyacrylamide gel electrophoresis followed by 
immunoblotting. 
 
4.4.6. Chromatin immunoprecipitation assays (ChIP) 
 
ChIP assays were carried out as previously described (Prince et al., 2004). Briefly, WI-
38 cells (60%-70% confluence) were serum starved 24 hr prior to treatment with TPA or 
vehicle. Cells were fixed in 1% formaldehyde after 8 hr treatment. The chromatin was 
extracted, sonicated and immunoprecipitated using antibodies against Sp1. DNA 
precipitation was analyzed by PCR using human TBX2 specific primer pairs (Forward: 





































The T-box family of transcription factors play a central role in embryonic development 
and is an important aspect of developmental biology. T-box members are expressed in 
specific cell types and are required for the development of their associated tissues and 
organs (Dobrovolskaïa-Zavadskaa, 1927). Their important regulatory roles in 
development have been demonstrated by mutational studies where mutant alleles, 
including heterozygotes, commonly give a phenotype. In humans for example, ulnar-
mammary syndrome is caused by mutations in TBX3 (Bamshad et al., 1997), Holt-Oram 
syndrome is linked to haplo-insufficiency of TBX5 (Li et al., 1997) and mutations within 
TBX1 have been associated with DiGeorge syndrome (Jerome et al., 2001; Lindsay et 
al., 2001; Mersher et al., 2001). 
 
Human TBX2 has not yet been linked to any known genetic syndrome but has been 
implicated in limb, heart and mammary gland development (King et al., 2006; Plageman 
and Yutzey, 2005; Rowley et al., 2004). Targeted mutagenesis to investigate Tbx2 
function in mice have shown that heterozygous mutants appear normal while 
homozygous mutants die between 10.5 and 14.5 days post coitum of cardiac 
insufficiency (Plageman and Yutzey, 2005). TBX2 has also been implicated in 
tumourigenesis because its expression is deregulated in many melanoma, breast and 
pancreatic cancers (Mahlamaki et al., 2002; Packham and Brook, 2003; Sinclair et al., 
2002; Vance et al., 2005) and it can suppress senescence through a mechanism 
involving its ability to repress expression of the cell cycle regulatory genes, p19ARF and 
p21WAF1/CIP1/SD11 (Jacobs et al., 2000; Prince et al., 2004). Understanding the molecular 
role of Tbx2 in embryonic development and its impact on cell cycle control continues to 
represent a major challenge, in part, because its target genes and transcriptional 
regulation are still poorly characterised.  
 
The present study thus contributes signifcantly to this knowledge base by firstly 
providing evidence that the COL1A2 gene is a candidate target of Tbx2, and that Tbx2 
may exert its effect on this gene as a co-repressor depending on the cell context and/or 











characterising the proximal promoter region of the gene, thus setting the stage for 
studying the regulation of the TBX2 gene. Finally, this study reveals that TBX2 gene 
expression is stimulated by the PKC signalling pathway through a mechanism involving 
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-1606   gtagggataacggtcgcagaggccatactgcttccgccggtcccgaatccgcactgccaggagagatccg 
 
-1536   gccttcaaacgctgctcccaacgttcaacaacgaagtgccctgcgaccggtgtgcgcagtgggcgggcgc 
 
-1456   ctgcatgggtcaatgttggatgtacgcgcccaccacgcggttgtacgggtgggaatgtcacccgtggcta 
 
-1386   gtgcatgctctgtcttttccttcagaaCacgaccttcaggaatcagcctgagtgttcgcgcccgagcccg 
 
-1316   attggaagcaggtgcgtggtcgcttcactctccccgtgcacaccttgagttatagctctcgctgcgcaca 
 
-1246   gagggcaccacacggggcccgacacacacacacacacacacacacacacacacacaccatcacttcatgg 
 
-1176   gggggaaactgaggctgccggaagacagaaaacgaagactgatcacagaagagggggcttcaatcacagg 
                                  MluI 
-1106   tgctcgcagacaccccaactccctcacgcgttactcagcactccttaacttaggagacgtgcgcttccga 
 
-1036   gagatgagaagaaactaaaaaagtggttggcagggcgaagagaggaagccggtatttcggaagaaggaga 
                        KpnI 
-966   ctttcgtctccggtaccggatagggcgaaaattcgttgggtcgcgggtggagaatccggggtccgcccgc 
 
-896    gcggtgccgccctgtgctcagcgaaaggtgcgctcaccttcctggccccgaggaCccgctcctcccggcc 
 
-826    gctggaaagctcagggcggggcccgggcctgcggagaactccaggttccttccgagtcttccggtgaagg 
 
-756    cgggcgcgggtagggggtccccgcgtttccccagcgcaaggccgcgtcccgctcccgcccgcgccggccc 
 
-686    cagcagggctcggccatggctccactcaccagctcccgccacctgggatccgctcccggacctcggccgc 
 
-616    ccgagcctcccgactcgcccgcccaccggcctcgctttccagtgcctgctgtctctttccggggcgcagg 
 
-546    gacccccaggcggcgccacgacccggagctgggtcggaggccaggctggggctcgggccagagcggccgg 
 
-476    gcctctgggcgcgggagaaggagggcgccccctctccgctcggggtcgtgtcaatgctttgcacttgggg 
                                                 SmaI 
-406    ccggcgtgcggctgcgggtccttccccaaggccccgggacccgggctcccctcgcctcaggccctttcgg 
 
-336    cgggtcaggtcggccctccgcgctctccagtccggcgcaggcagccgcaggcgcgggcgggcggtggggg 
                                                         SspI 
-266    ccggggcaggaggaggggtctcggggcccggcggcccgtcattggttaatattttattctgttgacatgt 
 
-196    tttcttactgctgaggcttccgacaccttctcccaggccccccctcccggccggagcttggcctgagctg 
 
-126    tcaaaaccccgcccccggagacccacaattggtccaaaaagcgtaaaatcagcaatcaaggggggcctgg 
                                                   +1  
-56     ctcgttagcgcaggggatccgagctgggcaggacatgtgagatagtcacagttttcCAGAGATCACGAC 
         BglII  
         AGATCTAACCAGTCGCGCG 
 
The DNA sequence of the 5’-flanking region of  human TBX2 gene cloned from WI38 cell. 
Recognition sites for restriction enzymes BglII, SspI, SmaI, KpnI, and MluI are labeled. 



























































































Oligonucleotides used to generate mutant TBX2 proximal promoter by site-
directed mutagenesis 
 
Oligonucleotide                         sequence (5’ to 3’) 
 
 
Mut A  Forward         CCGGCCGGAGCTTGGCCgttGCTtTCAAAACCCCGCCC 
Mut B  Forward         TGGCCTGAGCTGTCAAAgtaCCGCCCCCGGAGACCCAC      
Mut C  Forward         GACATGTTTTCTTACTGCTGAttaTTCCGACACCTTCTCCCA  
Mut D  Forward         GACATGTTTTCTTACTGCcaAGGCTTCCGACACCTTCTC  
Mut E  Forward         GTTTTCTTACTGCTGAGGCTctCGACACCTTCTCCCAG    
Mut F  Forward         CTGTTGACATGTTTTCTTACacCTGAGGCTTCCGACACCT   
Mut G  Forward         CCAAAAAGCGTAAAATCAGCAAgttAGGGGGGCCTGGCTCGT  
Mut H  Forward         TGGTCCAAAAAGCGTAAAATtttCAATCAAGGGGGGCCTGGCTC 
Mut I  Forward         CAGCAATCAAGGGGGaCgTGGCTCGTTAGCGCA 
Mut J  Forward         CAGCAATCAAGGGGGGCCatGtTCGTTAGCGCAGGGGA 
Mut K  Forward         GTCAAAACCCCGCCCCCGtttACCCACAATTGGTCCAA 
Mut L  Forward         AGGGGGGCCTGGCTCGTTAttttAGGGGATCCGAGCTGGGCA  
           


















500 ng of the proximal TBX2 promoter (-216/+32) construct, its mutant construct were 
co-transfected with 50 ng pRL-TK into HT1080 cells. Firefly luciferase activity was 
normalized to renilla luciferase activity. The basal activity of the -216/+32 construct was 
set at 100%..  
 
 
